Abstract is: Familial Mediterranean fever (FMF) is a hereditary inflammatory disorder. FMF is an autoinflammatory disease caused by mutations in Mediterranean fever gene, which encodes a 781–amino acid protein called pyrin. While all ethnic groups are susceptible to FMF, it usually occurs in people of Mediterranean origin—including Sephardic Jews, Mizrahi Jews, Ashkenazi Jews, Assyrians, Armenians, Azerbaijanis, Levantines, Kurds, Greeks, Turks and Italians. The disorder has been given various names, including familial paroxysmal polyserositis, periodic peritonitis, recurrent polyserositis, benign paroxysmal peritonitis, periodic disease or periodic fever, Reimann periodic disease or Reimann syndrome, Siegal-Cattan-Mamou disease, and Wolff periodic disease. Note that "periodic fever" can also refer to any of the periodic fever syndromes.
designated intractable/rare disease | Q42303753 |
class of disease | Q112193867 |
rare disease | Q929833 |
disease | Q12136 |
urticarial syndrome | Q7901363 |
genetic disease | Q200779 |
autoimmune disease | Q8084905 |
autosomal genetic disease | Q18553442 |
P2176 | drug or therapy used for treatment | (+/-)-Colchicine | Q26998324 |
P2293 | genetic association | MEFV | Q14881867 |
P1995 | health specialty | rheumatology | Q327657 |
P5008 | on focus list of Wikimedia project | WikiProject Medicine | Q4099686 |
P780 | symptoms and signs | abdominal pain | Q183425 |
myalgia | Q474959 | ||
inflammation | Q101991 | ||
rash | Q653197 | ||
fever | Q38933 | ||
chest pain | Q693058 |
Q62034343 | A Diagnostic Test for Familial Mediterranean Fever |
Q65350401 | A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies |
Q125812076 | Alaa Shreiteh |
Q66081129 | An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes |
Q64220563 | Association Between Basal Proteinuria Levels and Pregnancy Outcomes in Familial Mediterranean Fever |
Q113888201 | Characterization of a Functional Test for Mediterranean Family Fever Screening - 2 |
Q66070954 | Colchicine Levels in the Serum of FMF (Familial Mediterranean Fever) Patients |
Q64611412 | Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation |
Q64171012 | Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency |
Q113916762 | Effects of Online Aerobic Exercise Training and Physical Activity Counseling in Juvenile Familial Mediterranean Fever |
Q63836040 | Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever |
Q113923759 | Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine |
Q63830152 | Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF) |
Q95718447 | Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic |
Q66061310 | Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics |
Q64173456 | Gluten-related Disorders in Familial Mediterranean Fever Patients |
Q64656135 | Heat Intolerance in the Group of FMF Patients |
Q66403143 | Ilaris (Canakinumab) in Patient With Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA) |
Q64186142 | Immunome Project Consortium for Autoinflammatory Disorders |
Q65389818 | Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission |
Q66031730 | Interleukin-1 Trap to Treat Autoinflammatory Diseases |
Q64639653 | Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever |
Q86285810 | Lanadelumab in FXII-associated Cold Autoinflammatory Syndrome (FACAS) |
Q64721205 | Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients |
Q64185602 | Musculoskeletal Ultrasound of the Ankles in Erysipelas-like Erythema of Familial Mediterranean Fever |
Q64353957 | Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases |
Q61938188 | Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients |
Q95718057 | Pilates Based Exercises in Patients With Behçet and Familial Mediterranean Fever. |
Q65333380 | Probiotics and Corticosteroids for Treating Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA) |
Q63397588 | Quality of Life in Patients With Auto-inflammatory Diseases |
Q64726542 | Rilonacept for Treatment of Familial Mediterranean Fever (FMF) |
Q113927333 | Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever |
Q64335791 | Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers |
Q67126411 | The Comparison of the Efficacy of Once and Twice Daily Colchicine Dosage in Pediatric Patients With FMF |
Q64350297 | The Effect of Probiotics on Response to Therapy and on Adverse Effect in Patients Treated With Colchicine for Familial Mediterranean Fever. |
Q113914898 | The Movement Imagery Ability in Patients With Familial Mediterranean Fever |
Q64171132 | Tocilizumab for the Treatment of Familial Mediterranean Fever |
Q54847542 | GM14978 |
Q116049466 | HPS2924 |
Q116049467 | HPS2925 |
Q116049468 | HPS2926 |
Q116049469 | HPS2927 |
Q116049471 | HPS2928 |
Q116049472 | HPS2929 |
Q54900691 | KU_FMF_iPSC_1 |
Q40309600 | 'Silent' carriage of two familial Mediterranean fever gene mutations in large families with only a single identified patient |
Q33599350 | 1Novel MEFV transcripts in Familial Mediterranean fever patients and controls |
Q40844605 | 2 cases of familial mediterranean fever in subjects originating from the inland of the Marche region |
Q92291773 | 50 Years Ago in The Journal of Pediatrics: Intestinal Obstruction Complicating Familial Mediterranean Fever |
Q59409055 | 8th International Congress of Familial Mediterranean Fever and Systemic Autoinflammatory Diseases |
Q47561773 | A 44-Year-Old Female with Familial Mediterranean Fever, Cardiomyopathy and End Stage Renal Disease |
Q92030482 | A 44-year-old female with familial Mediterranean fever, cardiomyopathy and end stage renal disease |
Q36638040 | A Case Report of Familial Mediterranean Fever Diagnosed Following the Total Knee Arthroplasty |
Q47565063 | A Case of Familial Mediterranean Fever Having Intermittent Leukopenia |
Q40833407 | A Case of Familial Mediterranean Fever with Cutaneous Vasculitis and Immune Complex Nephritis: Light, Electron, and Immunofluorescent Study of Renal Biopsy |
Q55083339 | A Case of Familial Mediterranean Fever with Extensive Lymphadenopathy and Complex Heterozygous Genotype Presenting in the Fourth Decade. |
Q89686028 | A Case of Familial Mediterranean Fever without Fever |
Q40715288 | A Dutch family with familial Mediterranean fever |
Q83377700 | A Japanese case of familial Mediterranean fever presenting diffuse bone marrow uptake of FDG-PET and high levels of neutrophil membrane CD64 expression |
Q40371954 | A Japanese case of familial Mediterranean fever with a MEFV gene mutation. |
Q40552049 | A Japanese case of familial Mediterranean fever with family history demonstrating a mutation in MEFV. |
Q40501545 | A Japanese case of familial Mediterranean fever with homozygosity for the pyrin E148Q mutation |
Q40479064 | A Japanese case of familial Mediterranean fever with onset in the fifties. |
Q40101079 | A Japanese familial Mediterranean fever patient with a rare G632S MEFV mutation in exon 10. |
Q40364594 | A Japanese family with adult-onset familial Mediterranean fever and periodic episodes of high fever and abdominal pain |
Q40511634 | A Japanese patient with familial Mediterranean fever associated with compound heterozygosity for pyrin variant E148Q/M694I. |
Q41927574 | A Nationwide Experience With The Off-label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients. |
Q40106344 | A Rare Coincidence of Sitosterolemia and Familial Mediterranean Fever Identified by Whole Exome Sequencing |
Q84013541 | A case of Familial Mediterranean Fever at the Baltic Sea |
Q58326288 | A case of amyloid myopathy in a patient with familial Mediterranean fever |
Q40866085 | A case of familial Mediterranean fever |
Q40699102 | A case of familial Mediterranean fever and Niemann-Pick disease |
Q73029430 | A case of familial Mediterranean fever and polyarteritis nodosa complicated by spontaneous bilateral perirenal and subcapsular splenic haemorrhage |
Q40542578 | A case of familial Mediterranean fever and polyarteritis nodosa complicated by spontaneous perirenal and subcapsular hepatic hemorrhage requiring multiple arterial embolizations |
Q40372185 | A case of familial Mediterranean fever associated with compound heterozygosity for the pyrin variant L110P-E148Q/M680I in Japan |
Q40105850 | A case of familial Mediterranean fever who complained of periodic fever and abdominal pain diagnosed by MEFV gene analysis |
Q40592597 | A case of familial Mediterranean fever with amyloidosis as the first manifestation |
Q40692787 | A case of familial Mediterranean fever with obvious family history |
Q40781425 | A case of familial Mediterranean fever with paroxysmal pseudo-obstruction of bowel |
Q86527073 | A case of familial Mediterranean fever with triple MEFV gene mutations |
Q77399077 | A case of familial Mediterranean fever, Behçet's disease and polyarteritis nodosa complicated by perirenal haematoma |
Q40804312 | A case of periodic fever resembling familial Mediterranean fever, suppressed effectively by colchicine |
Q40870636 | A case of recurrent arthro-peritonitis (familial Mediterranean fever) with Raynaud's syndrome |
Q81597429 | A case of recurrent pancreatitis due to hyperlipidemia misdiagnosed as familial Mediterranean fever |
Q82214309 | A case with multiple sclerosis and familial Mediterranean fever |
Q38163822 | A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin |
Q92552302 | A closer look at familial Mediterranean fever cases in a large breast cancer dataset |
Q40528736 | A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis |
Q92986112 | A comprehensive molecular analysis and genotype-phenotype correlation in patients with familial mediterranean fever |
Q40880843 | A cytogenic evaluation of long-term colchicine therapy in the treatment of Familial Mediterranean Fever (FMF) |
Q80707000 | A disease must be considered in the differential diagnosis of ascites: familial Mediterranean fever |
Q40990111 | A disease of many names. (Benign paroxysmal peritonitis, Armenian's disease, familial recurring polyserositis, periodic disease, familial Mediterranean fever, periodic peritonitis, periodic abdominalgia). |
Q92759263 | A familial Mediterranean fever patient with double homozygous mutations treated with anakinra after kidney transplantation |
Q53194309 | A familial mediterranean fever flare induced by a drug reaction with eosinophilia and systemic symptoms. |
Q38890430 | A high-resolution genetic map of the familial Mediterranean fever candidate region allows identification of haplotype-sharing among ethnic groups. |
Q40497323 | A microscopic study of kidney tissue in Familial Mediterranean Fever patients |
Q40283257 | A molecular analysis of familial Mediterranean fever disease in a cohort of Turkish patients |
Q46507220 | A molecular basis for the absence of familial Mediterranean fever in Ethiopian Jews. |
Q91916268 | A new MEFV gene mutation in an Iranian patient with familial Mediterranean fever |
Q40397895 | A new set of criteria for the diagnosis of familial Mediterranean fever in childhood |
Q73115134 | A note on mutation analysis in familial Mediterranean fever |
Q38693064 | A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy |
Q21261477 | A novel insertion mutation identified in exon 10 of the MEFV gene associated with Familial Mediterranean Fever |
Q40446212 | A novel mutation of the familial Mediterranean fever gene in a Greek family related to a non-classical, variably expressed FMF phenotype. |
Q40776333 | A patient with familial Mediterranean fever |
Q40930070 | A patient with the nephropathic form of familial Mediterranean fever |
Q40382442 | A population genetics study of the familial Mediterranean fever gene: evidence of balancing selection under an overdominance regime |
Q91648644 | A rapidly growing mature mediastinal teratoma with a testicular epidermoid cyst and familial Mediterranean fever |
Q40179934 | A rare coincidence of torticollis in Familial Mediterranean Fever: atlanto-axial rotatory subluxation |
Q40349965 | A rare presentation of familial mediterranean Fever; acute scrotum and hydrocele amyloidosis |
Q40427418 | A renal transplant recipient with delayed gastric emptying in amyloidosis due to familial Mediterranean fever improved with erythromycin: a case report |
Q40484785 | A respiratory splash of monocytes and neutrophils in familial Mediterranean fever |
Q62658659 | A severe autosomal-dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the MEFV H478Y variant in a Spanish kindred: An unusual familial Mediterranean fever phenotype or another MEFV-associated per |
Q40604151 | A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behçet's disease (FMF-BD). |
Q38877225 | A study of familial Mediterranean Fever (MEFV) gene mutations in Egyptian children with type 1 diabetes mellitus. |
Q37708258 | A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever |
Q96348910 | A systematic literature review of efficacy, effectiveness and safety of biologic therapies for treatment of familial Mediterranean fever |
Q39042895 | A trial of diphenylhydantoin in periodic disease (familial Mediterranean fever) in Egyptian children |
Q40434545 | A very frequent mutation and remarkable association of R761H with M694V mutations in Turkish familial Mediterranean fever patients |
Q40207945 | A young girl with familial Mediterranean fever and abdominal pain |
Q40040838 | AA Amyloidosis and Atypical Familial Mediterranean Fever with Exon 2 and 3 Mutations |
Q40426013 | ABCC6 is unlikely to be a modifier gene for familial Mediterranean fever severity |
Q40640509 | Abdominal CT in familial Mediterranean fever: a case report |
Q71943048 | Absence of circulating antineutrophil cytoplasmic antibodies in familial Mediterranean fever |
Q73516865 | Abstracts of the III International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders. Montpellier, France. September 2002 |
Q35677969 | Acquired familial Mediterranean fever associated with a somatic MEFV mutation in a patient with JAK2 associated post-polycythemia myelofibrosis |
Q40381544 | Acute adrenal crisis mimicking familial Mediterranean fever attack in a renal transplant FMF patient with amyloid goiter |
Q40198122 | Acute pericarditis as the first manifestation of familial Mediterranean fever: a possible relationship with idiopathic recurrent pericarditis |
Q77397098 | Acute phase response and evolution of familial Mediterranean fever |
Q40311003 | Acute phase response and oxidative stress status in familial Mediterranean fever (FMF). |
Q35550951 | Acute phase response in familial Mediterranean fever |
Q40799690 | Acute pleuritic chest pain with pleural effusion and plate atelectasis. Familial Mediterranean fever (periodic disease). |
Q80210884 | Acute renal failure in a patient with familial Mediterranean fever |
Q40700281 | Acute scrotal pain complicating familial Mediterranean fever in children |
Q40687290 | Adhesive small bowel obstruction caused by Familial Mediterranean Fever: The incidence and outcome |
Q46336979 | Adrenomedullin levels in patients with Familial Mediterranean Fever: a long term follow-up |
Q46969466 | Adrenomedullin levels in patients with Familial Mediterranean Fever: a long term follow-up |
Q34135074 | Adult-onset familial mediterranean Fever in northwestern iran; clinical feature and treatment outcome |
Q34608120 | Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy |
Q90708041 | Age dependent safety and efficacy of colchicine treatment for familial Mediterranean fever in children |
Q93126210 | Age dependent safety and efficacy of colchicine treatment for familial mediterranean fever in children |
Q93058224 | Age of onset as an influencing factor for disease severity in children with familial Mediterranean fever |
Q73548008 | Allogenic bone marrow transplantation: not a treatment yet for familial Mediterranean fever |
Q47336099 | Alteration of the microRNA expression profile in familial Mediterranean fever patients |
Q84233999 | Altered circadian rhythm: possible trigger of familial Mediterranean fever attacks |
Q90096608 | Altered expression of apoptosis-related, circulating cell-free miRNAs in children with familial Mediterranean fever: a cross-sectional study |
Q24290622 | Alternative splicing at the MEFV locus involved in familial Mediterranean fever regulates translocation of the marenostrin/pyrin protein to the nucleus |
Q40867618 | Amelioration of Familial Mediterranean Fever during Hemodialysis |
Q40215842 | Amyloid A amyloidosis in a Japanese patient with familial Mediterranean fever associated with homozygosity for the pyrin variant M694I/M694I. |
Q34249465 | Amyloid goiter as the initial manifestation of systemic amyloidosis due to familial mediterranean fever with homozygous MEFV mutation |
Q40185809 | Amyloid goiter due to familial mediterranean Fever in a patient with byler syndrome: a case report |
Q34450610 | Amyloid goiter in Familial Mediterranean Fever (FMF): a clinicopathologic study of 10 cases |
Q72204413 | Amyloid goiter in a child with familial Mediterranean fever |
Q33619546 | Amyloid goiter: two cases and a review of the literature |
Q35007167 | Amyloid goitre in familial Mediterranean fever: report on three patients and review of the literature |
Q40812970 | Amyloidosis and familial Mediterranean fever |
Q40223693 | Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study |
Q34107561 | Amyloidosis and periodic peritonitis (familial mediterranean Fever) |
Q40928389 | Amyloidosis as a manifestation of familial mediterranean fever in siblings |
Q40987119 | Amyloidosis as the sole manifestation of familial Mediterranean fever (FMF). Further evidence of its genetic nature |
Q74099799 | Amyloidosis in Behçet's disease and familial Mediterranean fever |
Q69146459 | Amyloidosis in children with familial Mediterranean fever |
Q24623012 | Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects |
Q77677105 | Amyloidosis in familial mediterranean fever is associated with a specific ancestral haplotype in the MEFV locus |
Q40891614 | Amyloidosis in familial mediterranean fever: clinical and renal-biopsy features (author's transl) |
Q35550032 | Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene |
Q79367077 | Amyloidosis of familial Mediterranean fever (FMF)--insights to FMF phenotype II |
Q34115528 | Amyloidosis of familial mediterranean fever and the MEFV gene |
Q90847003 | An Extraordinary Complication in a Child With Combined Familial Mediterranean Fever and Inflammatory Bowel Disease: Multiple Ileal Perforations |
Q40140811 | An Insidious Danger in Children With Familial Mediterranean Fever: Colchicine Intoxication |
Q58562732 | An International Delphi Survey for the Definition of New Classification Criteria for Familial Mediterranean Fever, Mevalonate Kinase Deficiency, TNF Receptor-associated Periodic Fever Syndromes, and Cryopyrin-associated Periodic Syndrome |
Q64101692 | An adult case of atypical familial Mediterranean fever (pyrin-associated autoinflammatory disease) similar to adult-onset Still's disease |
Q40277574 | An atypical familial Mediterranean fever patient who developed ulcers in the terminal ileum and recurrent abscess-like lesions in multiple organs |
Q92374708 | An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance: Study protocol for investigator-initiated, multicenter, open-label trial |
Q37522280 | An overview of familial Mediterranean fever with emphasis on pyrin and colchicine. |
Q40421934 | An unusual association between familial mediterranean fever and IgM nephropathy |
Q40471134 | An unusual complication of familial Mediterranean fever: intestinal volvulus and necrosis. |
Q40468026 | An unusual complication of familial Mediterranean fever: protracted arthritis with bilateral coxarthrosis and intraosseous amyloidosis of femoral head. |
Q40533308 | An unusual presentation of familial Mediterranean fever with prolonged hip pain and amyloidosis |
Q40079604 | Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial |
Q51729796 | Anakinra in two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever: effective but risky. |
Q40137623 | Anakinra induces complete remission of nephrotic syndrome in a patient with familial mediterranean fever and amyloidosis. |
Q40402428 | Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient |
Q55227334 | Anakinra treatment in patients with Familial Mediterranean Fever: a single-center experience. |
Q104138316 | Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience |
Q37679308 | Anakinra use during pregnancy: Report of a case with Familial Mediterranean Fever and infertility |
Q40417172 | Anakinra: new therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine |
Q33984080 | Analysis of MEFV exon methylation and expression patterns in familial Mediterranean fever |
Q39091856 | Analysis of common MEFV mutations in Egyptian patients with familial Mediterranean fever: molecular characterisation of the disease |
Q40413303 | Analysis of familial Mediterranean fever gene mutations in 202 patients with familial Mediterranean fever |
Q101452960 | Analysis of polymorphisms in the colchicine binding site of tubulin in colchicine-resistant familial Mediterranean fever patients |
Q47137785 | Analysis of the Most Common Three MEFV Mutations in 630 Patients with Familial Mediterranean Fever in Iranian Azeri Turkish Population |
Q56288694 | Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever |
Q96817025 | Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis |
Q49575531 | Ankylosing Spondylitis among Familial Mediterranean Fever Patients |
Q37196923 | Anti-CCP Antibodies Are Not Associated with Familial Mediterranean Fever in Childhood |
Q40191340 | Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis |
Q37874985 | Anti-TNF agents in familial Mediterranean fever: report of three cases and review of the literature. |
Q40340639 | Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine |
Q92212955 | Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis |
Q71457787 | Anti-neutrophil cytoplasmic antibodies in familial Mediterranean fever |
Q61455785 | Antineutrophil cytoplasmic antibody-positive familial Mediterranean fever and hyperthyroidism: A case report |
Q40219987 | Anxiety and depression in adult patients with familial Mediterranean fever: a study comparing patients living in Germany and Turkey |
Q40045054 | Aortic Flow Propagation Velocity in Patients with Familial Mediterranean Fever: an Observational Study. |
Q40275925 | Apoptosis-associated speck-like protein containing a CARD (ASC) expression profiles in familial Mediterranean fever (FMF) patients with different MEFV mutation patterns |
Q40409430 | Appendectomy in familial Mediterranean fever: clinical, genetic and pathological findings. |
Q40053238 | Are children with familial Mediterranean fever really vitamin D deficient? |
Q79425845 | Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF |
Q98213073 | Are there any clinical differences between ankylosing spondylitis patients and familial mediterranean fever patients with ankylosing spondylitis? |
Q40468516 | Arg753Gln TLR-2 polymorphism in familial mediterranean fever: linking the environment to the phenotype in a monogenic inflammatory disease. |
Q40920259 | Arterial hypertension and nephropathy in familial Mediterranean fever |
Q92284386 | Arterial stiffness in Familial Mediterranean Fever: correlations with disease-related parameters and colchicine treatment |
Q72088239 | Arthritis in familial Mediterranean Fever |
Q40348520 | Arthritis patterns in familial Mediterranean fever patients and association with M694V mutation. |
Q40243529 | As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio |
Q40248917 | Assesment life quality of familial Mediterranean fever patients by short form-36 and its relationship with disease parameters |
Q87035695 | Assessing disease severity and activity in patients with familial Mediterranean fever |
Q97426341 | Assessment of Circulating Microribonucleic Acids in Patients With Familial Mediterranean Fever |
Q93140225 | Assessment of Epicardial Adipose Tissue Thickness in Children with Familial Mediterranean Fever |
Q35983351 | Assessment of MEFV Gene Mutations in Exon 10 in Familial Mediterranean Fever Patients from Iranian Azeri and Turkish Population |
Q64891826 | Assessment of Mean Platelet Volume in Patients with AA Amyloidosis and AA Amyloidosis Secondary to Familial Mediterranean Fever: A Retrospective Chart - Review Study. |
Q82267189 | Assessment of aortic stiffness and ventricular functions in familial Mediterranean fever |
Q83630014 | Assessment of aortic stiffness and ventricular functions in familial Mediterranean fever |
Q40205987 | Assessment of autonomic functions in children with familial Mediterranean fever by using heart rate variability measurements |
Q89450463 | Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever |
Q33560996 | Assessment of neutrophil to lymphocyte ratio and mean platelet volume in pediatric familial Mediterranean fever patients |
Q46518372 | Assessment of pyrin gene mutations in Turks with familial Mediterranean fever (FMF). |
Q38225736 | Assessment of renal involvement in patients with familial Mediterranean fever: a clinical study from Ardabil, Iran |
Q40133586 | Association Between Keratoconus and Familial Mediterranean Fever in Turkey |
Q40123745 | Association Between Vitamin D Receptor Polymorphism and Familial Mediterranean Fever Disease in Turkish Children |
Q83923277 | Association between ankylosing spondylitis and familial Mediterranean fever |
Q91751176 | Association between basal proteinuria levels and pregnancy outcomes in familial Mediterranean fever |
Q53350240 | Association between familial mediterranean fever and retroperitoneal fibrosis: retroperitoneal fibrosis regression after colchicine therapy. |
Q64118774 | Association of Vasculitis and Familial Mediterranean Fever |
Q82692337 | Association of familial Mediterranean fever and celiac disease in a 14-year-old girl with recurrent arthritis |
Q40151444 | Association of familial Mediterranean fever in Turkish children with inflammatory bowel disease |
Q40103601 | Association of hidradenitis suppurativa and familial Mediterranean fever: A case series of 6 patients. |
Q40267560 | Association of inflammatory bowel disease with familial Mediterranean fever in Turkish children. |
Q104489884 | Attacks of TNF-receptor associated periodic syndrome are associated with higher inflammatory markers than familial Mediterranean fever |
Q40643181 | Attacks of pericarditis as a manifestation of familial Mediterranean fever (FMF). |
Q45744733 | Attacks of severe dysmenorrhea as the sole manifestation of Familial Mediterranean Fever (FMF). |
Q91322842 | Atypical Familial Mediterranean Fever Complicated with Gastrointestinal Amyloidosis Diagnosed due to Paroxysmal Arthralgia and Intractable Diarrhea, Successfully Treated with Tocilizumab |
Q91776376 | Atypical Familial Mediterranean Fever Presenting with Recurrent Migratory Polyarthritis |
Q47551807 | Atypical familial Mediterranean fever developed in a long-term hemodialysis patient |
Q91706127 | Atypical familial mediterranean fever with PFAPA-Like symptoms and psoriasis |
Q90409522 | Atypical phenotype without fever in a Japanese family with an autosomal dominant transmission of familial Mediterranean fever due to heterozygous MEFV Thr577Asn mutations |
Q90467940 | Atypical type of familial Mediterranean fever: An underdiagnosed cause of chronic aseptic meningitis |
Q40755756 | Autoantibodies in familial Mediterranean fever (recurrent polyserositis). |
Q92132475 | Autoinflammation: Lessons from the study of familial Mediterranean fever |
Q40108613 | Autoinflammation: When is familial Mediterranean fever 'severe'? |
Q40107240 | Autosomal dominant familial Mediterranean fever in Northern European Caucasians associated with deletion of p.M694 residue-a case series and genetic exploration |
Q40526529 | Avascular necrosis of the femoral head foreshadowing familial Mediterranean fever: apropos of three cases |
Q42978204 | Azoospermia in familial Mediterranean fever patients: the role of colchicine and amyloidosis |
Q80036967 | Behcet's disease and familial Mediterranean fever |
Q45745470 | Behçet Disease (BD) in two siblings affected with Familial Mediterranean Fever (FMF). |
Q39253541 | Behçet's disease and familial Mediterranean fever: Two sides of the same coin or just an association? A cross-sectional study. |
Q40621738 | Behçet's disease in Familial Mediterranean fever: characterization of the association between the two diseases |
Q72883882 | Beta-2-microglobulin levels of dialysis patients with renal amyloidosis secondary to familial Mediterranean fever |
Q40101086 | Biologic therapy in familial Mediterranean fever: Comment on the study by Koga et al |
Q38373493 | Biological agents in familial Mediterranean fever focusing on colchicine resistance and amyloidosis |
Q89006710 | Blood group 'A' may have a possible modifier effect on familial Mediterranean fever and blood group '0' may be associated with colchicine resistance |
Q92091121 | Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever |
Q39223011 | Bloody Diarrhea as a Presentation Manifestation of Familial Mediterranean Fever in a Patient with Compound Heterozygote Mutations of the MEFV Gene |
Q36404591 | Bone Mineral Density in Egyptian Children with Familial Mediterranean Fever |
Q31068003 | Bone mineral density in children with familial Mediterranean fever |
Q49922867 | Boundaries between familial Mediterranean fever and juvenile spondyloarthritis: Analysis of three French retrospective cohorts |
Q40246448 | Brain stem infarction associated with familial Mediterranean fever and central nervous system vasculitis |
Q70223053 | Breast-feeding during colchicine therapy for familial Mediterranean fever |
Q40565063 | CT findings in patients with familial Mediterranean fever during an acute abdominal attack |
Q90340684 | Can Calprotectin Show Subclinical Inflammation in Familial Mediterranean Fever Patients? |
Q40209256 | Can colchicine response be predicted in familial Mediterranean fever patients? |
Q46969732 | Can serum amyloid a level be used to support the Familial Mediterranean Fever diagnosis? |
Q82713506 | Can we use faecal calprotectin to distinguish abdominal pain of familial Mediterranean fever (FMF) from acute appendicitis? |
Q52583643 | Canakinumab as monotherapy for treatment of familial Mediterranean fever - first report in Central and Eastern Europe region. |
Q35535362 | Canakinumab as rescue therapy in familial Mediterranean fever refractory to conventional treatment |
Q91275650 | Canakinumab eliminates resistant familial Mediterranean fever in a Japanese girl |
Q40199493 | Canakinumab for the treatment of children with colchicine-resistant familial Mediterranean fever: a 6-month open-label, single-arm pilot study |
Q92972216 | Canakinumab in Children with Familial Mediterranean Fever: A Single-Center, Retrospective Analysis |
Q94958636 | Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases |
Q49950020 | Canakinumab treatment in children with familial Mediterranean fever: report from a single center |
Q89452376 | Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever |
Q91532414 | Cancer incidence in familial Mediterranean fever patients: a retrospective analysis from central Anatolia |
Q101038925 | Cardiovascular disease risk assessment in patients with familial Mediterranean fever related renal amyloidosis |
Q33149792 | Cardiovascular reactivity score for the assessment of dysautonomia in familial Mediterranean fever |
Q86913030 | Case of familial Mediterranean fever presenting with constant abdominal pain |
Q40847674 | Case report 195: inflammatory synovitis due to familial Mediterranean fever (FMF) of left third metatarso-phalangeal joint |
Q88527794 | Case report: acute hydrops and spontaneous corneal perforation in a patient with keratoconus treated with colchicine for familial Mediterranean fever |
Q40274616 | Case report; A Japanese case of familial Mediterranean fever with onset in the thirties |
Q40204378 | Case report; A Japanese case of familial Mediterranean fever with pleurisy |
Q40323179 | Case report; a case of familial Mediterranean fever diagnosed in adult |
Q40215243 | Case report; a case of familial Mediterranean fever identified by periodic fever associated with the menstrual cycle |
Q73404731 | Central nervous system demyelination in familial Mediterranean fever: Is it a coincidence? |
Q54293199 | Challenging case of Familial Mediterranean Fever and its management. |
Q47696953 | Changing concepts in familial Mediterranean fever: is it possible to have an autosomal-recessive disease with only one mutation? |
Q40509830 | Characteristics of patients with adult-onset familial Mediterranean fever in Turkey: analysis of 401 cases |
Q96828437 | Characteristics of patients with familial Mediterranean fever in Denmark: a retrospective nationwide register-based cohort study |
Q39877055 | Characterization of new mutations in the 5'-flanking region of the familial Mediterranean fever gene. |
Q52659306 | Chemotherapy-Colchicine Interaction in a Child with Familial Mediterranean Fever and Hodgkin Lymphoma. |
Q40385332 | Childhood stroke in a child with familial Mediterranean fever carrying several prothrombotic risk factors |
Q87263265 | Choroidal Changes in Patients with Familial Mediterranean Fever |
Q74430544 | Chronic ascites related to encapsulating peritonitis in familial Mediterranean fever |
Q40658562 | Chronic colchicine treatment does not impair glucose tolerance in familial Mediterranean fever patients |
Q59268795 | Chronic destructive arthritis as an isolated symptom of familial Mediterranean fever (FMF) in a 17 year old Turkish boy |
Q40854601 | Chronic destructive arthritis in familial Mediterranean fever: the predominance of hip involvement and its management |
Q40330904 | Chronic familial Mediterranean fever with development of secondary amyloidosis. |
Q91754941 | Chronic inflammation in adult familial Mediterranean fever patients: underlying causes and association with amyloidosis |
Q90735911 | Chronic non-bacterial osteomyelitis coexistent with familial Mediterranean fever |
Q33561486 | Chronic synovitis of the shoulder in familial Mediterranean fever: a disease of symptoms not signs |
Q40867277 | Circulating immune complexes in familial Mediterranean fever, systemic lupus erythematosus and HBsAg carriers |
Q40858317 | Circulating immune complexes in recurrent polyserositis. (Familial mediterranean fever, periodic disease). |
Q40559721 | Cisplatin Treatment Triggers Familial Mediterranean Fever Attacks |
Q40126255 | Clinical Profile of Familial Mediterranean Fever in a Paediatric Population in Eastern Turkey |
Q57033800 | Clinical and Demographic Evaluation According to MEFV Genes in Patients with Familial Mediterranean Fever |
Q96018894 | Clinical and Genetic Analysis of 22 Japanese Patients with Familial Mediterranean Fever: An Examination of MEFV and 10 Other Genes Related to Autoinflammatory Syndromes |
Q59268725 | Clinical and demographic characteristics of children with familial mediterranean fever in Central Anatolia |
Q37521441 | Clinical and genetic features of familial Mediterranean fever in Japan |
Q88066433 | Clinical and genetic heterogeneity in a large cohort of Armenian patients with late-onset familial Mediterranean fever |
Q50106385 | Clinical and genetic peculiarities of vasculitis associated with Familial Mediterranean fever in Armenian children. |
Q39447786 | Clinical and molecular diagnosis of Familial Mediterranean Fever in Egyptian children. |
Q24300638 | Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations |
Q101164009 | Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area |
Q74590267 | Clinical differences between North African and Iraqi Jews with familial Mediterranean fever |
Q36603948 | Clinical features and functional significance of the P369S/R408Q variant in pyrin, the familial Mediterranean fever protein |
Q40386905 | Clinical features of familial Mediterranean fever: an Italian overview. |
Q80034811 | Clinical improvement with infliximab in a child with amyloidosis secondary to familial Mediterranean fever |
Q40456693 | Clinical study of 7 cases of familial Mediterranean fever with MEFV gene mutation. |
Q90330108 | Clinicopathological Assessment of Kidney Biopsies in Children with Familial Mediterranean Fever: A Single-Center Experience |
Q52180455 | Cloning of the familial Mediterranean fever gene: expectations for learning about the pathogenesis of amyloid A amyloidosis. |
Q40227758 | Cluster of patients with Familial Mediterranean fever and heterozygous carriers of mutations in MEFV gene in the Czech Republic. |
Q40396077 | Co-existence of Hashimoto's thyroiditis with familial Mediterranean fever: is there a pathophysiological association between the two diseases? |
Q40508800 | Co-existence of Helicobacter pylori infection in patients with Familial Mediterranean Fever (FMF) and the effect of Helicobacter pylori on the frequency and severity of FMF attacks |
Q40200911 | Co-existence of familial Mediterranean fever and multiple sclerosis in two patients |
Q28241517 | Co-occurrence of familial Mediterranean fever (FMF) heterozygote mutation and nail-patella syndrome (NPS) in 3 members of a family with LMX1B mutation analysis |
Q40145103 | Cochlear functions in children with familial Mediterranean fever: any role of the severity of the disease? |
Q40302393 | Cochlear involvement in Familial Mediterranean Fever: a new feature of an old disease |
Q38679038 | Coexistence of Behçet's disease with ankylosing spondylitis and familial Mediterranean fever: a rare occurrence |
Q89099453 | Coexistence of Familial Mediterranean Fever With Ankylosing Spondylitis and Sjogren's Syndrome: A Rare Occurrence |
Q93162500 | Coexistence of Mixed Connective Tissue Disease and Familial Mediterranean Fever in a Japanese Patient |
Q40474392 | Coexistence of familial Mediterranean fever and Behçet's disease in a Japanese patient. |
Q92894771 | Coexistence of familial Mediterranean fever and Behçet's disease: a case report |
Q80195910 | Coexistence of familial Mediterranean fever and Sjögren's syndrome in a Japanese patient |
Q37709062 | Coexistence of familial Mediterranean fever and juvenile idiopathic arthritis with osteoporosis successfully treated with etanercept |
Q40418476 | Coexistence of familial Mediterranean fever and psoriasis in a patient with seronegative spondyloarthropathy |
Q40227427 | Coexistence of familial Mediterranean fever and rheumatoid arthritis |
Q77522009 | Coexistence of familial Mediterranean fever with sacroiliitis and Behçet's disease: a rare occurrence |
Q40148216 | Coexistence of hereditary angioedema in a case of familial Mediterranean fever with partial response to colchicine |
Q80690060 | Coexistence of lichen aureus with familial Mediterranean fever |
Q86038578 | Coexistence of systemic lupus erythematosus and familial Mediterranean fever |
Q43512226 | Coexistence of systemic lupus erythematosus and familial Mediterranean fever in a pediatric patient |
Q42753824 | Coexistent MEFV and CIAS1 mutations manifesting as familial Mediterranean fever plus deafness |
Q96433370 | Coexisting Diseases in Patients with Familial Mediterranean Fever |
Q83286057 | Cogan's syndrome in a patient with familial Mediterranean fever |
Q84405209 | Colchicine and ocular surface changes in familial Mediterranean fever |
Q40702608 | Colchicine disposition in patients with familial Mediterranean fever with renal impairment. |
Q40201809 | Colchicine failure in familial Mediterranean fever and potential alternatives: embarking on the anakinra trial |
Q69483875 | Colchicine for Familial Mediterranean Fever |
Q69566260 | Colchicine for familial Mediterranean fever |
Q70256592 | Colchicine for familial Mediterranean fever |
Q40854428 | Colchicine for familial Mediterranean fever (author's transl) |
Q66695289 | Colchicine in familial Mediterranean fever |
Q40677645 | Colchicine in familial Mediterranean fever: practical problems and their solutions |
Q73914406 | Colchicine in the treatment of renal amyloidosis secondary to familial Mediterranean fever |
Q41928182 | Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients |
Q40242047 | Colchicine modulates expression of pro-inflammatory genes in neutrophils from patients with familial Mediterranean fever and healthy subjects |
Q28319676 | Colchicine myopathy in a case of familial Mediterranean fever: immunohistochemical and ultrastructural study of accumulated tubulin-immunoreactive material |
Q40552663 | Colchicine myopathy in a patient with familial Mediterranean fever and normal renal function |
Q40539863 | Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization |
Q68122991 | Colchicine prevents kidney transplant amyloidosis in familial Mediterranean fever |
Q40751866 | Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years |
Q39245123 | Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments |
Q35817991 | Colchicine therapy for nephrotic syndrome due to familial Mediterranean fever |
Q40873795 | Colchicine therapy in familial Mediterranean fever |
Q40232999 | Colchicine treatment in children with familial Mediterranean fever: is it a risk factor for neuromyopathy? |
Q77399072 | Colchicine treatment in familial Mediterranean fever: an indirect effect on in vitro serum amyloid A secretion via leukocyte derived factors |
Q36714926 | Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement |
Q91839606 | Colchicine's Effects on Electrocardiographic Parameters in Newly Diagnosed Familial Mediterranean Fever Patients : Colchicine may have Favourable Effects on Parameters Related to Ventricular Arrhythmias in New Diagnosed Familial Mediterranean Fever |
Q38554404 | Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori |
Q37493594 | Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control study |
Q40542084 | Colchicine-induced leukopenia in a patient with familial Mediterranean fever: the cause and a possible approach. |
Q90859393 | Colchicine-induced myoneuropathy with myotonia in a patient with familial Mediterranean fever |
Q40161741 | Colchicine-resistant familial Mediterranean fever in a renal transplantation patient: successful treatment with anakinra |
Q92950412 | Cold-induced urticaria in a child with familial Mediterranean fever |
Q40226966 | Colonic lymphoid nodular hyperplasia in childhood: causes of familial Mediterranean fever need extra attention |
Q90762878 | Comment on 'Age dependent safety and efficacy of colchicine treatment for familial Mediterranean fever in children' |
Q89059805 | Comment on: Coexistence of systemic lupus erythematosus and familial Mediterranean fever in a pediatric patient |
Q89069095 | Comment on: Different disease subtypes with distinct clinical expression in familial Mediterranean fever: results of a cluster analysis |
Q86076891 | Comment on: Dysregulated mature IL-1β production in familial Mediterranean fever |
Q86076887 | Comment on: Dysregulated mature IL-1β production in familial Mediterranean fever: reply |
Q84131587 | Comment on: Familial Mediterranean fever caused by homozygous E148Q mutation complicated by Budd-Chiari syndrome and polyarteritis nodosa |
Q58853100 | Comment on: Familial Mediterranean fever caused by homozygous E148Q mutation complicated by Budd-Chiari syndrome and polyarteritis nodosa: reply |
Q64039737 | Comment on: Familial Mediterranean fever: breaking all the (genetic) rules |
Q91749687 | Comment on: Improvement of MEFV gene variants classification to aid treatment decision making in familial Mediterranean fever |
Q92000953 | Comment on: Improvement of MEFV gene variants classification to aid treatment decision making in familial Mediterranean fever: reply |
Q92039278 | Comment on: Short-term follow-up results of children with familial Mediterranean fever after cessation of colchicine: is it possible to quit? |
Q92039295 | Comment on: Short-term follow-up results of children with familial Mediterranean fever after cessation of colchicine: is it possible to quit?: reply |
Q99713147 | Comment on: Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus |
Q100958984 | Comment on: Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus: reply |
Q91825584 | Comment on: Tofacitinib for familial Mediterranean fever: a new alternative therapy? |
Q91825549 | Comment on: Tofacitinib for familial Mediterranean fever: a new alternative therapy?: reply |
Q87494313 | Comment on: different disease subtypes with distinct clinical expression in familial Mediterranean fever: results of a cluster analysis: reply |
Q43926369 | Comment on: small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening |
Q91313652 | Commentary to "A 44-year-old female with familial Mediterranean fever, cardiomyopathy and end stage renal disease" by Magaki et al |
Q39806185 | Common Familial Mediterranean Fever gene mutations in a Turkish cohort |
Q40356422 | Common MEFV mutation analysis in 36 Iranian patients with familial Mediterranean fever: clinical and demographic significance. |
Q40561053 | Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients |
Q94455396 | Comorbidities and phenotype-genotype correlation in children with familial Mediterranean fever |
Q90622110 | Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients |
Q92879487 | Comparison of Pediatric Familial Mediterranean Fever Patients Carrying Only E148Q Variant With the Ones Carrying Homozygous Pathogenic Mutations |
Q81352522 | Comparison of amplification refractory mutation system and polymerase chain reaction-restriction fragment length polymorphism techniques used for the investigation of MEFV gene exon 10 point mutations in familial Mediterranean fever patients living |
Q90789790 | Comparison of familial Mediterranean fever and juvenile idiopathic arthritis patients according to family origin |
Q91996368 | Comparison of optical coherence tomography angiography results of adult patients with Familial Mediterranean fever and healthy individuals |
Q41928011 | Comparison of patients with familial Mediterranean fever accompanied with sacroiliitis and patients with juvenile spondyloarthropathy |
Q40040817 | Comparison of serum inflammatory cytokine concentrations in familial Mediterranean fever and rheumatoid arthritis patients |
Q40200848 | Comparison of serum oxidant and antioxidant parameters in familial Mediterranean fever patients (FMF) with attack free period |
Q60926780 | Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial |
Q86683533 | Complete remission of nephrotic syndrome in a woman with renal amyloidosis due to familial mediterranean fever |
Q92072234 | Complexity of familial Mediterranean fever genetics |
Q104142257 | Compliance of Familial Mediterranean Fever Patients With Regular Follow-up Visits and Associated Factors |
Q54901405 | Compliance to colchicine treatment and disease activity in Familial Mediterranean Fever (FMF) patients in Middle/Black Sea Region of Turkey (in Çorum region). |
Q81780751 | Composition of urinary glycosaminoglycans in a patient with pseudoxanthoma elasticum and familial Mediterranean fever |
Q92511927 | Concomitance of Familial Mediterranean Fever and Gitelman syndrome in an adolescent |
Q40273387 | Concomitance of Gitelman syndrome and familial Mediterranean fever: a rare case presentation |
Q83485732 | Concomitant amyloidosis, renal papillary carcinoma and ipsilateral pelvicalyceal urothelial carcinoma in a patient with familial Mediterranean fever |
Q39192500 | Concordance between CRP and SAA in familial Mediterranean fever during attack-free period: A study of 218 patients |
Q40650630 | Construction of a 1-Mb restriction-mapped cosmid contig containing the candidate region for the familial Mediterranean fever locus (MEFV) on chromosome 16p 13.3. |
Q22008521 | Construction of an approximately 700-kb transcript map around the familial Mediterranean fever locus on human chromosome 16p13.3 |
Q81219412 | Continuous ambulatory peritoneal dialysis in familial Mediterranean fever amyloidosis patients with end-stage renal failure: a single-centre experience from Turkey |
Q40890131 | Continuous colchicine therapy in familial mediterranean fever |
Q73687256 | Corneal wound healing in a patient treated with colchicine for familial Mediterranean Fever (FMF) |
Q40848682 | Correction of a suppressor cell deficiency and amelioration of familial Mediterranean fever by hemodialysis |
Q40850885 | Correction of a suppressor cell deficiency in familial Mediterranean fever by colchicine. |
Q40842093 | Correction of a suppressor cell deficiency in four patients with familial Mediterranean fever by in vitro or in vivo colchicine. |
Q70330819 | Correction of nonsuppressible responder cells by colchicine in familial Mediterranean fever |
Q90930636 | Correction to: Evaluation of the effects of miRNAs in familial Mediterranean fever |
Q87672490 | Correction: rilonacept for colchicine-resistant or -intolerant familial mediterranean Fever |
Q100315351 | Correspondence on 'Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial' |
Q90783337 | Corticosteroid-resistant anakinra-responsive protracted febrile myalgia syndrome as the first manifestation of familial Mediterranean fever |
Q40132670 | Cost of Familial Mediterranean Fever (Fmf) Disease In Turkey |
Q92559412 | Could blood products obtained from patients with familial Mediterranean fever have beneficial or harmful effects? |
Q40139844 | Could familial Mediterranean fever gene mutations be related to PFAPA syndrome? |
Q33761003 | Coupling clinical exome sequencing with functional characterization studies to diagnose a patient with familial Mediterranean fever and MED13L haploinsufficiency syndromes |
Q40507604 | Cryoglobulinemia and other dysproteinemias, familial Mediterranean fever, and POEMS syndrome. |
Q40255803 | Cutaneous polymorph manifestations of familial Mediterranean fever in a child |
Q40807538 | Cyclosporine and familial Mediterranean fever amyloidosis |
Q40258593 | Cystatin C in serum as an early marker of renal involvement in Familial Mediterranean Fever patients |
Q40416812 | Decreased bone mineral density in adult familial Mediterranean fever patients: a pilot study. |
Q40736363 | Decreased interleukin 1 activity released from circulating monocytes of patients with familial Mediterranean fever during in vitro stimulation by lipopolysaccharide |
Q104491183 | Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach |
Q37902519 | Delay in diagnosis of intestinal obstruction in a patient with familial mediterranean Fever |
Q54839551 | Deletion in MEFV resulting in the loss of p.M694 residue as the cause of autosomal dominant familial Mediterranean fever in North Western European Caucasians - a case series and genetic exploration. |
Q40383565 | Demographic, clinical and mutational characteristics of Turkish familial Mediterranean fever patients: results of a single center in Central Anatolia |
Q40807214 | Destructive arthropathy in familial Mediterranean fever |
Q92078509 | Detection of Familial Mediterranean Fever attacks by using a connected activity tracker and assessment of impact of attacks to daily physical activities: a pilot study |
Q58133778 | Deteriorated Systolic Blood Pressure Recovery and Heart Rate Recovery After Graded Exercise in Children With Familial Mediterranean Fever |
Q40749696 | Determination of autoantibodies in patients with familial Mediterranean fever and their first degree relatives. |
Q40570045 | Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers |
Q96017045 | Development and Validation of a Quality of Life Scale in Familial Mediterranean Fever (FMFQoL) |
Q38914751 | Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF). |
Q40138235 | Development of a medication adherence scale for familial Mediterranean fever (MASIF) in a cohort of Turkish children. |
Q50416748 | Development of focal segmental glomerulosclerosis in a patient with Familial Mediterranean Fever resistant to colchicine therapy under treatment with Canakinumab. |
Q72582640 | Diagnosing familial Mediterranean fever |
Q37840999 | Diagnosis and management of familial Mediterranean fever: integrating medical genetics in a dedicated interdisciplinary clinic |
Q40505550 | Diagnosis delay in familial Mediterranean fever (FMF): social and gender gaps disclosed. |
Q43836043 | Diagnosis of familial Mediterranean fever by a molecular genetics method |
Q39678848 | Diagnosis of familial Mediterranean fever following the initial presentation of monoarthritis |
Q56288691 | Diagnostic and treatment concerns in familial Mediterranean fever |
Q47784140 | Diagnostic value of MEFV gene analysis in familial Mediterranean fever must still be assessed in non-classically affected populations: comment on the article by Cazeneuve et al. |
Q45744749 | Differences in the severity of the phenotype of children and adolescents with Familial Mediterranean Fever residing in Turkey and Germany |
Q40516305 | Different ELR (+) angiogenic CXC chemokine profiles in synovial fluid of patients with Behçet's disease, familial Mediterranean fever, rheumatoid arthritis, and osteoarthritis |
Q40139398 | Different disease subtypes with distinct clinical expression in familial Mediterranean fever: results of a cluster analysis |
Q92971197 | Different pharmaceutical preparations of colchicine for Familial Mediterranean Fever: are they the same? |
Q38745967 | Differential Expression of miR-4520a Associated With Pyrin Mutations in Familial Mediterranean Fever (FMF). |
Q40778668 | Differential diagnosis and therapy of cycle-dependent severe attacks of familial Mediterranean fever |
Q40865277 | Differential diagnosis of familial Mediterranean fever and systemic connective tissue diseases in children |
Q46196488 | Differential expression of miR-4520a is associated with gain of function mutations in Familial Mediterranean Fever (FMF). |
Q98578536 | Differential mutational profiles of familial Mediterranean fever in North Africa |
Q36110186 | Diffuse and multifocal nephrogenic adenoma with Familial Mediterranean Fever: a case report with molecular study |
Q40284857 | Diffuse pulmonary amyloidosis due to Familial Mediterranean Fever, a rare presentation. |
Q40377553 | Diffusion-weighted MRI of the kidneys in patients with familial Mediterranean fever: initial experience |
Q40634425 | Direct detection of common mutations in the familial Mediterranean fever gene (MEFV) using naturally occurring and primer mediated restriction fragment analysis. Mutation in brief no. 257. Online |
Q90621566 | Disease Severity and Genotype Affect Physical Growth in Children With Familial Mediterranean Fever |
Q40240676 | Disease severity in adult patients of Turkish ancestry with familial mediterranean fever living in Germany or Turkey. Does the country of residence affect the course of the disease? |
Q40409302 | Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease |
Q43263627 | Do MTHFR mutations kick in during familial mediterranean fever attacks? |
Q40225567 | Do neutrophil gelatinase-associated lipocalin and interleukin-18 predict renal dysfunction in patients with familial Mediterranean fever and amyloidosis? |
Q103738107 | Does Age at Onset Affect the Clinical Presentation of Familial Mediterranean Fever in Children? |
Q40054045 | Does familial Mediterranean fever affect cognitive function in children? Electrophysiological preliminary study |
Q42537727 | Does the lack of the P-glycoprotein efflux pump in neutrophils explain the efficacy of colchicine in familial Mediterranean fever and other inflammatory diseases? |
Q45745843 | Does unity of Familial Mediterranean fever with juvenile idiopathic arthritis affect the outcome? |
Q89377753 | Dominant familial Mediterranean fever |
Q95806382 | Dominant inheritance in two families with familial Mediterranean fever (FMF) |
Q68082519 | Dopamine-beta-hydroxylase activity in familial Mediterranean fever |
Q40313887 | Down-regulation of adiponectin in patients with familial Mediterranean fever during attack-free period. |
Q40311616 | Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure |
Q35555482 | E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean fever |
Q49186368 | E148Q of the MEFV gene causes amyloidosis in familial Mediterranean fever patients |
Q38844701 | EFFECT OF FAMILIAL MEDITERRANEAN FEVER ON IVF OUTCOME: A RETROSPECTIVE CASE SERIES. |
Q26775286 | EULAR recommendations for the management of familial Mediterranean fever |
Q40478988 | Early and severe amyloidosis in a patient with concurrent familial Mediterranean fever and pseudoxanthoma elasticum. |
Q44904230 | Early suppression of familial Mediterranean fever attacks by single medium dose methyl-prednisolone infusion |
Q36056815 | Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever |
Q66896357 | Editorial: Colchicine in familial Mediterranean fever |
Q96586927 | Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience |
Q40242170 | Effect of chronic periodontitis on serum and gingival crevicular fluid oxidant and antioxidant status in patients with familial Mediterranean fever before and after periodontal treatment |
Q40820997 | Effect of colchicine on the amyloidosis of familial Mediterranean fever |
Q40060348 | Effect of familial Mediterranean fever on sexual and reproductive health in women |
Q90395019 | Effect of interleukin-1 antagonists on the quality of life in familial Mediterranean fever patients |
Q42753852 | Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra |
Q87470328 | Effective treatment with azathioprine for renal amyloidosis secondary to familial Mediterranean fever |
Q90497508 | Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients: A Single-Center Real-Life Study |
Q93190818 | Effects of Familial Mediterranean Fever on Cardiac Functions in Adults: A Cross-Sectional Study Based on Speckle Tracking Echocardiography |
Q40311082 | Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment |
Q100502083 | Effects of familial Mediterranean fever on the middle ear |
Q47554645 | Effects of mating patterns on genealogical trees: assessment of the high carrier rate of Familial Mediterranean Fever in rural Israeli districts |
Q36027314 | Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever |
Q88172826 | Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis |
Q90859044 | Efficacy and safety of long-term treatment with intravenous colchicine for familial Mediterranean fever (FMF) refractory to oral colchicine |
Q38674665 | Efficacy and safety of treatments in Familial Mediterranean fever: a systematic review |
Q36798016 | Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature |
Q99613263 | Efficacy of anti-interleukin-1 treatment in colchicine-resistant arthritis in patients with familial Mediterranean fever |
Q43188930 | Efficacy of colchicine in familial Mediterranean fever is well established |
Q57820585 | Endoscopic Findings of Children with Familial Mediterranean Fever |
Q57301721 | Endoscopic findings in patients with familial Mediterranean fever and dyspeptic symptoms |
Q46363085 | Endothelial biomarkers in patients with familial Mediterranean fever associated vascular disease and vasculopathy |
Q40426604 | Engaging anti-inflammatory mechanisms and triggering inflammatory effector apoptosis during Familial Mediterranean Fever attack. |
Q43900488 | Enigmas in familial Mediterranean fever (FMF). |
Q99401025 | Enthesitis may be one of the signs of severe disease in familial Mediterranean fever |
Q40260236 | Enthesopathy in patients with familial Mediterranean fever: increased prevalence in M694 V variant. |
Q92380596 | Epidemiology and management of familial Mediterranean fever in Armenia: national audit from 1999 to 2018 |
Q53780404 | Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey. |
Q73395414 | Epithelial cell-derived neutrophil activator-78 levels in children with familial Mediterranean fever |
Q93555669 | Erratum to "The First Case of Familial Mediterranean Fever Associated with Renal Amyloidosis in Korea" by Koo KY, et al. (Yonsei Med J 2012;53:454-8.). |
Q93557594 | Erratum to "The First Case of Familial Mediterranean Fever Associated with Renal Amyloidosis in Korea" by Koo KY, et al. (Yonsei Med J 2012;53:454-8.). |
Q40042054 | Erratum: Neurological Manifestations in Familial Mediterranean Fever: Results of 22 Children from a Reference Center in Kayseri, an Urban Area in Central Anatolia, Turkey |
Q43413446 | Erysipelas-like erythema as a cutaneous sign of familial Mediterranean fever: a case report and review of the histopathologic findings |
Q101124721 | Erysipelas-like erythema in children with familial Mediterranean fever |
Q40253603 | Erysipelas-like erythema of familial Mediterranean fever syndrome: a case report with emphasis on histopathologic diagnostic clues |
Q40622815 | Erysipelas-like erythema of familial Mediterranean fever: clinicopathologic correlation |
Q83478003 | Erysipelas-like erythema with familial Mediterranean fever |
Q40381457 | Esophageal motor function in Familial Mediterranean Fever: a prospective evaluation of motility in 31 patients |
Q40995896 | Ethnic distribution and amyloidosis in familial Mediterranean fever (FMF). |
Q40301173 | Evaluating MEFV mutation frequency in Turkish familial Mediterranean fever suspected patients and gender correlation: a retrospective study |
Q35646557 | Evaluation of Ovarian Reserve with Anti-Müllerian Hormone in Familial Mediterranean Fever |
Q97562841 | Evaluation of a Proarrhythmic Repolarization Marker (Total Cosine R to T) in Patients With Uncomplicated Familial Mediterranean Fever |
Q92585625 | Evaluation of analytical factors associated with targeted MEFV gene sequencing using long-range PCR/massively parallel sequencing of whole blood DNA for molecular diagnosis of Familial Mediterranean fever |
Q92226904 | Evaluation of co-existing diseases in children with familial Mediterranean fever |
Q39028024 | Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation |
Q98569474 | Evaluation of familial Mediterranean fever patients concomitant with juvenile spondyloarthropathy |
Q49805845 | Evaluation of familial mediterranean fever patients: a single center experience |
Q91456620 | Evaluation of hearing in pediatric familial Mediterranean fever patients during attack period and attack-free period |
Q40418469 | Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis |
Q40515634 | Evaluation of joints using Tc 99m-MDP bone scintigraphy in patients with familial Mediterranean fever: should bone scans be used for diagnosis and follow-up? |
Q44171570 | Evaluation of mean platelet volume in familial Mediterranean fever; insight from the methodological aspect |
Q40344294 | Evaluation of nailfold capillaries in familial Mediterranean fever patients |
Q40383663 | Evaluation of pathergy test positivity in familial Mediterranean fever patients and comparison of clinical manifestations of FMF with Behçet's disease |
Q91218590 | Evaluation of pentraxin-3 in familial Mediterranean fever patients during attack and attack-free periods |
Q87326866 | Evaluation of platelet indices in children with familial Mediterranean fever: confounding factors should be considered |
Q104285534 | Evaluation of serum CXC chemokine ligand 16 (CXCL16) as a novel inflammatory biomarker for Familial Mediterranean Fever disease |
Q39829020 | Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study. |
Q92603814 | Evaluation of the Burden of Care and the Quality of Life in the Parents of Turkish Children with Familial Mediterranean Fever |
Q90427567 | Evaluation of the structure, autoimmunity, and functions of the thyroid gland in familial Mediterranean fever patients |
Q104681637 | Evaluation of the thicknesses of cartilage and enthesis in familial Mediterranean fever and enthesitis-related arthritis |
Q100388356 | Evaluation of the thyroid disorders in children with familial Mediterranean fever |
Q40305078 | Evaluation of various cardiac autonomic indices in patients with familial Mediterranean fever on colchicine treatment |
Q40716041 | Evidence for linkage of the gene causing familial Mediterranean fever to chromosome 17q in non-Ashkenazi Jewish families: second locus or type I error? |
Q40343268 | Evidence for the involvement of mTOR inhibition and basal autophagy in familial Mediterranean fever phenotype |
Q37218181 | Evidence of oxidative stress in erythrocyte phospholipid composition in the pathogenesis of familial Mediterranean fever (periodical disease). |
Q40200257 | Ex vivo PBMC cytokine profile in familial Mediterranean fever patients: Involvement of IL-1β, IL-1α and Th17-associated cytokines and decrease of Th1 and Th2 cytokines |
Q49927925 | Exacerbation of Behçet's syndrome and familial Mediterranean fever with menstruation |
Q40745807 | Exclusion of linkage between familial Mediterranean fever and the human serum amyloid A (SAA) gene cluster |
Q33680761 | Exclusion of the familial Mediterranean fever locus as a susceptibility region for autosomal dominant familial Hibernian fever |
Q40275398 | Exertional leg pain as a manifestation of occult spondyloarthropathy in familial Mediterranean fever: an MRI evaluation |
Q40191007 | Exertional leg pain in familial Mediterranean fever: a manifestation of an underlying enthesopathy and a marker of more severe disease |
Q39521224 | Exertional muscle pain in familial Mediterranean fever patients evaluated by MRI and 31P magnetic resonance spectroscopy |
Q40409672 | Expression of ASC in renal tissues of familial mediterranean fever patients with amyloidosis: postulating a role for ASC in AA type amyloid deposition |
Q40618764 | Expression of the familial Mediterranean fever gene and activity of the C5a inhibitor in human primary fibroblast cultures |
Q40379908 | Expression of the familial Mediterranean fever gene is regulated by nonsense-mediated decay |
Q40257854 | Extensive thrombosis in a patient with familial Mediterranean fever, despite hyperimmunoglobulin D state in serum. [corrected]. |
Q70486243 | Eye involvement in a patient with familial Mediterranean fever |
Q40981934 | FAMILIAL MEDITERRANEAN FEVER SIMULATING RHEUMATIC CARDITIS. |
Q98512211 | FAMILIAL MEDITERRANEAN FEVER, FROM PATHOGENESIS TO TREATMENT: A CONTEMPORARY REVIEW |
Q73345498 | Fabry's disease mimicking familial Mediterranean fever |
Q96644524 | Factors associated with damage in patients with familial Mediterranean fever |
Q34657952 | Falling into TRAPS--receptor misfolding in the TNF receptor 1-associated periodic fever syndrome |
Q40289119 | Familial Mediterranean FeVer gene (MEFV) mutations as a modifier of systemic lupus erythematosus |
Q45744726 | Familial Mediterranean Fever (FMF) and renal disease: first report on 29 Sicilian patients |
Q45744763 | Familial Mediterranean Fever (FMF) before the age of one year |
Q91542667 | Familial Mediterranean Fever (FMF): a single centre retrospective study in Amsterdam |
Q40513755 | Familial Mediterranean Fever (FMF): from diagnosis to treatment |
Q40266303 | Familial Mediterranean Fever -- an increasingly important childhood disease in Sweden |
Q96231052 | Familial Mediterranean Fever Complicated by a Triad of Adrenal Crisis: Amyloid Goiter and Cardiac Amyloidosis |
Q64292449 | Familial Mediterranean Fever Gene Mutations and Gout as an Auto-Inflammatory Arthropathy |
Q50099741 | Familial Mediterranean Fever Imitating Lupus Flare: A Rare Coexistence of an Autoimmune With an Autoinflammatory Disease |
Q41929698 | Familial Mediterranean Fever Is Associated With Increased Mortality After Kidney Transplantation-A 19 Years' Single Center Experience |
Q58581935 | Familial Mediterranean Fever Is Commonly Diagnosed in Children in Israel with Periodic Fever Aphthous Stomatitis, Pharyngitis, and Adenitis Syndrome |
Q90068673 | Familial Mediterranean Fever Is Important in the Differential Diagnosis of Recurrent Aseptic Meningitis in Japan |
Q88742023 | Familial Mediterranean Fever Mutations in a Patient with Periodic Episodes of Systemic Pain Deriving from Cancer Bone Metastases |
Q40349713 | Familial Mediterranean Fever Presenting as Anti-Cyclic Citrullinated Peptide Antibody Negative Palindromic Rheumatism |
Q40089056 | Familial Mediterranean Fever Presenting with Recurrent Aseptic Meningitis: A Case Report. |
Q35777898 | Familial Mediterranean Fever With Complete Symptomatic Remission During Pregnancy |
Q100726912 | Familial Mediterranean Fever and COVID-19: Friends or Foes? |
Q54521894 | Familial Mediterranean Fever and Human autoinflammatory diseases. |
Q89498899 | Familial Mediterranean Fever and Multiple Sclerosis Successfully Treated With Interferon Beta-1a: A Case Report |
Q40474902 | Familial Mediterranean Fever and Primary Antiphospholipid Syndrome, a Rare Association |
Q53710197 | Familial Mediterranean Fever associated diseases in children. |
Q83593552 | Familial Mediterranean Fever coexisting with celiac disease: is there a link with long-term colchicine treatment? |
Q33622298 | Familial Mediterranean Fever developing in a Japanese kidney transplant recipient |
Q40422086 | Familial Mediterranean Fever in Armenian population. |
Q40901531 | Familial Mediterranean Fever in Armenians. Analysis of 100 cases. |
Q53062669 | Familial Mediterranean Fever in Ashkenazi Jews |
Q91711832 | Familial Mediterranean Fever in Chinese Children: A Case Series |
Q40430124 | Familial Mediterranean Fever in Crete: a genetic and structural biological approach in a population of 'intermediate risk'. |
Q36044321 | Familial Mediterranean Fever in Iran: A Report from FMF Registration Center |
Q40441368 | Familial Mediterranean Fever in Lebanon: founder effects for different MEFV mutations. |
Q40608322 | Familial Mediterranean Fever in a cold climate: read The Lancet |
Q40934551 | Familial Mediterranean Fever in an Italian Family |
Q50285969 | Familial Mediterranean Fever in childhood: a single center experience |
Q40172692 | Familial Mediterranean Fever in children and adolescents in Georgia |
Q46970654 | Familial Mediterranean Fever in older children |
Q40363862 | Familial Mediterranean Fever in the first two years of life: a unique phenotype of disease in evolution |
Q39958317 | Familial Mediterranean Fever is associated with abnormal ventricular repolarization indices |
Q40924237 | Familial Mediterranean Fever with Involvement of the Lungs |
Q104795929 | Familial Mediterranean Fever with Neonatal Onset: Case Report |
Q37383213 | Familial Mediterranean Fever with Rheumatoid Arthritis Complicated by Pulmonary Paragonimiasis |
Q91901894 | Familial Mediterranean Fever with Small Bowel Stenosis |
Q40913424 | Familial Mediterranean Fever, Amyloidosis and Pregnancy |
Q40141251 | Familial Mediterranean Fever: An Unusual Case Presentation |
Q92796536 | Familial Mediterranean Fever: Assessing the Overall Clinical Impact and Formulating Treatment Plans |
Q100738967 | Familial Mediterranean Fever: Clinical State Of The Art |
Q40081334 | Familial Mediterranean Fever: Diagnostic Difficulties in an Atypical Case |
Q40058672 | Familial Mediterranean Fever: Observations from a pilot gene expression microarray analysis study. |
Q37716794 | Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management |
Q40536507 | Familial Mediterranean Fever: a case of dominant transmission with variable penetrance |
Q37353389 | Familial Mediterranean Fever: a review for clinical management. |
Q90166434 | Familial Mediterranean Fever: an unusual cause of liver disease |
Q40590659 | Familial Mediterranean Fever: association of elevated IgD plasma levels with specific MEFV mutations |
Q58593824 | Familial Mediterranean Gene (MEFV) Mutation in Parents of Children with Familial Mediterranean Fever: What Are the Exceptions? |
Q42955761 | Familial Mediterranean fever (FMF) and beyond: a new horizon. Fourth International Congress on the Systemic Autoinflammatory Diseases held in Bethesda, USA, 6-10 November 2005. |
Q40334851 | Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohorts |
Q35165574 | Familial Mediterranean fever (FMF) and renal AA amyloidosis--phenotype-genotype correlation, treatment and prognosis. |
Q40917012 | Familial Mediterranean fever (FMF) and unspecific desensitization with bacterial antigens |
Q40490090 | Familial Mediterranean fever (FMF) in Lebanon and Jordan: a population genetics study and report of three novel mutations |
Q35195069 | Familial Mediterranean fever (FMF) in Moroccan Jews: demonstration of a founder effect by extended haplotype analysis |
Q40517425 | Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study |
Q40576728 | Familial Mediterranean fever (FMF) mutations occur frequently in the Greek-Cypriot population of Cyprus |
Q91257003 | Familial Mediterranean fever (FMF) phenotype in patients homozygous to the MEFV M694V mutation |
Q40231419 | Familial Mediterranean fever (FMF) with proteinuria: clinical features, histology, predictors, and prognosis in a cohort of 25 patients |
Q40591426 | Familial Mediterranean fever (FMF)-associated amyloidosis in childhood. Clinical features, course and outcome |
Q40993796 | Familial Mediterranean fever (FMF). |
Q40555573 | Familial Mediterranean fever (familial paraoxysmal polyserositis) |
Q40803401 | Familial Mediterranean fever (or recurrent polyserositis) |
Q40188918 | Familial Mediterranean fever (paroxismal polyserositis, familial recurring polyserositis, periodic disease) |
Q40984118 | Familial Mediterranean fever (periodic disease) associated with ankylopoietic spondylitis. (Apropos of a case) |
Q40992820 | Familial Mediterranean fever (periodic fever). |
Q39667569 | Familial Mediterranean fever (recurrent hereditary polyserositis) in Arabs--a study of 175 patients and review of the literature |
Q38658722 | Familial Mediterranean fever (recurrent hereditary polyserositis) in children: analysis of 88 cases |
Q40835009 | Familial Mediterranean fever (report of 3 Punjabi cases). |
Q40845080 | Familial Mediterranean fever - a congenital disorder of exaggerated response to endogenous interferon? |
Q40216945 | Familial Mediterranean fever - clinical picture, diagnosis and treatment |
Q40216939 | Familial Mediterranean fever - first experiences in Slovakia |
Q62937812 | Familial Mediterranean fever - renal involvement by diseases other than amyloid |
Q95618309 | Familial Mediterranean fever E148Q mutation, episodic fever and kidney allograft dysfunction |
Q48423107 | Familial Mediterranean fever abdominal pain during spinal anaesthesia |
Q71138113 | Familial Mediterranean fever after recovery from Schönlein- Henoch syndrome |
Q40552834 | Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations. |
Q40940469 | Familial Mediterranean fever among the Turkish people |
Q40499439 | Familial Mediterranean fever among the autoimmune diseases |
Q73395362 | Familial Mediterranean fever and Behçet's disease |
Q80934433 | Familial Mediterranean fever and Celiac sprue--are they related? |
Q40514664 | Familial Mediterranean fever and E148Q pyrin gene mutation in Greece |
Q37269693 | Familial Mediterranean fever and IgA nephropathy: case report and review of the literature. |
Q40471052 | Familial Mediterranean fever and acute anterior myocardial infarction in a young patient. |
Q40627428 | Familial Mediterranean fever and acute rheumatic fever: a pathogenetic relationship? |
Q40843271 | Familial Mediterranean fever and amyloidosis |
Q71112741 | Familial Mediterranean fever and amyloidosis |
Q40714538 | Familial Mediterranean fever and amyloidosis in children |
Q36321862 | Familial Mediterranean fever and ankylosing spondylitis in a patient with juvenile idiopathic arthritis: A case report and review of the literature |
Q91200133 | Familial Mediterranean fever and atherosclerosis in childhood and adolescence |
Q40357309 | Familial Mediterranean fever and central nervous system involvement: a case series |
Q40154208 | Familial Mediterranean fever and cryptogenic cirrhosis |
Q40181030 | Familial Mediterranean fever and demyelinating plaques in the central nervous system |
Q40734256 | Familial Mediterranean fever and electroencephalographic changes. A clinical case |
Q40749674 | Familial Mediterranean fever and familial amyloidotic polyneuropathy |
Q40855753 | Familial Mediterranean fever and fatty liver. effect of a long time colchicine treatment on triglyceride storage (author's transl) |
Q35166955 | Familial Mediterranean fever and glomerulonephritis and review of the literature |
Q40483124 | Familial Mediterranean fever and growth: effect of disease severity and colchicine treatment. |
Q40647691 | Familial Mediterranean fever and hyperimmunoglobulinemia D syndrome: two diseases with distinct clinical, serologic, and genetic features. |
Q41927578 | Familial Mediterranean fever and incidence of cancer An analysis of 8534 patients with 258,803 person-years |
Q35143035 | Familial Mediterranean fever and its implications for fertility and pregnancy. |
Q40362068 | Familial Mediterranean fever and membranous glomerulonephritis: report of a case |
Q40604381 | Familial Mediterranean fever and menstruation |
Q36170819 | Familial Mediterranean fever and mesangial proliferative glomerulonephritis: report of a case and review of the literature |
Q40647317 | Familial Mediterranean fever and multiple sclerosis |
Q40738292 | Familial Mediterranean fever and myeloma: an undescribed association |
Q40877832 | Familial Mediterranean fever and nephrotic syndrome in Turkey |
Q90303758 | Familial Mediterranean fever and periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: shared features and main differences |
Q40473145 | Familial Mediterranean fever and peritoneal malignant mesothelioma: a possible association? |
Q40740665 | Familial Mediterranean fever and polyarteritis nodosa |
Q44813418 | Familial Mediterranean fever and polyarteritis nodosa: experience of five paediatric cases. A causal relationship or coincidence? |
Q37956869 | Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases |
Q37892998 | Familial Mediterranean fever and seronegative arthritis. |
Q40613653 | Familial Mediterranean fever and systemic amyloidosis in untreated Turkish patients |
Q74353965 | Familial Mediterranean fever and the control of inflammation |
Q36339678 | Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. |
Q90649318 | Familial Mediterranean fever as a rare cause of recurrent monoarthritis |
Q40606089 | Familial Mediterranean fever as an unusual cause of acute scrotum |
Q40388009 | Familial Mediterranean fever as representative autoinflammatory disease |
Q35552711 | Familial Mediterranean fever associated pyrin mutations in Greece |
Q40183014 | Familial Mediterranean fever associated with MEFV mutations in a large cohort of Cypriot patients |
Q40349318 | Familial Mediterranean fever associated with menstruation. Efficacy of intermittent colchicine therapy. |
Q40124944 | Familial Mediterranean fever associated with optic neuritis, successfully treated with anti-interleukin 1 agents. |
Q47611050 | Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. |
Q40413693 | Familial Mediterranean fever attacks do not alter functional and morphologic tissue Doppler echocardiographic parameters |
Q58853104 | Familial Mediterranean fever caused by homozygous E148Q mutation complicated by Budd-Chiari syndrome and polyarteritis nodosa |
Q43626523 | Familial Mediterranean fever clinical and genetic features in Druzes and in Iraqi Jews: a preliminary study. |
Q40103160 | Familial Mediterranean fever complicated with refractory asthma: Successful treatment with colchicine |
Q71761120 | Familial Mediterranean fever crisis and lupus anticoagulant |
Q40619058 | Familial Mediterranean fever diagnosed by PCR. |
Q58326275 | Familial Mediterranean fever diagnosed in an elderly patient |
Q43725082 | Familial Mediterranean fever diagnostic criteria: comment on the article by Livneh et al. |
Q40410352 | Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery |
Q74399843 | Familial Mediterranean fever gene |
Q40182095 | Familial Mediterranean fever gene (MEFV) mutations and disease severity in systemic lupus erythematosus (SLE): implications for the role of the E148Q MEFV allele in inflammation |
Q35580006 | Familial Mediterranean fever gene (MEFV) mutations in patients with rheumatic heart disease |
Q40428734 | Familial Mediterranean fever gene and protection against asthma |
Q40408376 | Familial Mediterranean fever gene as a possible modifier of Sweet syndrome with chronic myelogenous leukemia |
Q40364188 | Familial Mediterranean fever gene mutation frequencies and genotype-phenotype correlations in the Aegean region of Turkey |
Q40082573 | Familial Mediterranean fever gene mutation frequencies in a sample Turkish population |
Q40211570 | Familial Mediterranean fever gene mutations as a risk factor for early coronary artery disease |
Q40154826 | Familial Mediterranean fever gene mutations in north-eastern part of Anatolia with special respect to rare mutations |
Q40427320 | Familial Mediterranean fever gene mutations in the Southeastern region of Turkey and their phenotypical features |
Q40376132 | Familial Mediterranean fever gene mutations in the inner northern region of Turkey and genotype-phenotype correlation in children. |
Q40580573 | Familial Mediterranean fever in 2 Japanese families. |
Q35630954 | Familial Mediterranean fever in 2003. Pathogenesis and management |
Q40666524 | Familial Mediterranean fever in Arab children: the high prevalence and gene frequency |
Q95455815 | Familial Mediterranean fever in Armenia in 2015: some interesting lessons |
Q40770339 | Familial Mediterranean fever in Armenians: autosomal recessive inheritance with high gene frequency |
Q40371650 | Familial Mediterranean fever in Ashkenazi Jews: the mild end of the clinical spectrum |
Q40863468 | Familial Mediterranean fever in Australia |
Q71310005 | Familial Mediterranean fever in Australia |
Q69758328 | Familial Mediterranean fever in Australian children |
Q35935474 | Familial Mediterranean fever in Canada |
Q90809326 | Familial Mediterranean fever in Chinese adult patients |
Q39042898 | Familial Mediterranean fever in Egypt |
Q40203361 | Familial Mediterranean fever in Georgia |
Q40268824 | Familial Mediterranean fever in Germany: clinical presentation and amyloidosis risk |
Q40277153 | Familial Mediterranean fever in Germany: epidemiological, clinical, and genetic characteristics of a pediatric population |
Q84252944 | Familial Mediterranean fever in Iranian children. First report from Iran |
Q40269732 | Familial Mediterranean fever in Japan |
Q90415472 | Familial Mediterranean fever in Jordanian Children: single centre experience |
Q40608924 | Familial Mediterranean fever in Lebanon: mutation spectrum, evidence for cases in Maronites, Greek orthodoxes, Greek catholics, Syriacs and Chiites and for an association between amyloidosis and M694V and M694I mutations. |
Q40804609 | Familial Mediterranean fever in Mexico City |
Q40532827 | Familial Mediterranean fever in Mexico City. A 20-year follow-up |
Q71992483 | Familial Mediterranean fever in Mexico City: 10-year follow-up |
Q40195639 | Familial Mediterranean fever in Syrian children: phenotype-genotype correlation. |
Q39998321 | Familial Mediterranean fever in Syrian patients: MEFV gene mutations and genotype-phenotype correlation |
Q40927013 | Familial Mediterranean fever in Turkey. A report of twenty cases |
Q40611101 | Familial Mediterranean fever in a 26-year old Lebanese man |
Q40775937 | Familial Mediterranean fever in a German family |
Q40598746 | Familial Mediterranean fever in a Taiwanese patient |
Q81626704 | Familial Mediterranean fever in a childhood population in eastern Turkey |
Q40749469 | Familial Mediterranean fever in a fraternal twin: a laboratory evaluation |
Q40346609 | Familial Mediterranean fever in a large Lebanese family: multiple MEFV mutations and evidence for a Founder effect of the p.[M694I] mutation |
Q40522393 | Familial Mediterranean fever in a pregnant woman |
Q40903698 | Familial Mediterranean fever in an Iraqi family |
Q72374146 | Familial Mediterranean fever in an individual of Maltese extraction: history is destiny |
Q40856800 | Familial Mediterranean fever in childhood (author's transl) |
Q38614765 | Familial Mediterranean fever in childhood: a single-center experience |
Q35524443 | Familial Mediterranean fever in children |
Q38599628 | Familial Mediterranean fever in children and adolescents: factors for colchicine dosage and predicting parameters for dose increase |
Q40122476 | Familial Mediterranean fever in children from the Aegean region of Turkey: gene mutation frequencies and phenotype-genotype correlation |
Q40364836 | Familial Mediterranean fever in children presenting with attacks of fever alone |
Q40456465 | Familial Mediterranean fever in children: a single centre experience in Jordan. |
Q40647672 | Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis |
Q40628218 | Familial Mediterranean fever in children: the expanded clinical profile |
Q40254151 | Familial Mediterranean fever in heterozygotes: are we able to accurately diagnose the disease in very young children? |
Q40423701 | Familial Mediterranean fever in northwest of Iran (Ardabil): the first global report from Iran |
Q40272805 | Familial Mediterranean fever in siblings |
Q38653403 | Familial Mediterranean fever in six Australian children. |
Q40307532 | Familial Mediterranean fever in small children in Turkey |
Q40681836 | Familial Mediterranean fever in the "Chuetas" of Mallorca--origin in inquisition? |
Q40620153 | Familial Mediterranean fever in the 'Chuetas' of Mallorca: a question of Jewish origin or genetic heterogeneity |
Q40480884 | Familial Mediterranean fever in the Syrian population: gene mutation frequencies, carrier rates and phenotype-genotype correlation. |
Q40721803 | Familial Mediterranean fever in the colchicine era: the fate of one family |
Q40784309 | Familial Mediterranean fever in the light of our observations |
Q36048174 | Familial Mediterranean fever in the post-genomic era: how an ancient disease is providing new insights into inflammatory pathways |
Q40431348 | Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations |
Q39368171 | Familial Mediterranean fever in two Bedouin families: mutation analysis and disease severity |
Q39446016 | Familial Mediterranean fever in two Italian brothers. |
Q35281058 | Familial Mediterranean fever in which Crohn's disease was suspected: a case report |
Q92489845 | Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study |
Q92469677 | Familial Mediterranean fever is associated with increased risk for ischaemic heart disease and mortality-Perspective derived from a large database |
Q40567503 | Familial Mediterranean fever is no longer a rare disease in Italy |
Q37139961 | Familial Mediterranean fever is no longer a rare disease in Japan |
Q72692375 | Familial Mediterranean fever is not associated with the antiphospholipid syndrome |
Q52728876 | Familial Mediterranean fever mimicking Crohn disease: A case report. |
Q73158048 | Familial Mediterranean fever mimicking Fitz-Hugh-Curtis syndrome |
Q40515284 | Familial Mediterranean fever mimicking septic arthritis |
Q40547696 | Familial Mediterranean fever mutation frequencies and carrier rates among a mixed Arabic population |
Q47638843 | Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome. |
Q58470542 | Familial Mediterranean fever mutations in a patient with recurrent episodes of acute respiratory distress syndrome |
Q37515104 | Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation |
Q40258836 | Familial Mediterranean fever occurring in an elderly Japanese woman with recent-onset rheumatoid arthritis |
Q40095229 | Familial Mediterranean fever patients homozygous for E148Q variant. |
Q51362550 | Familial Mediterranean fever patients may have unmet needs for treatment of erysipelas-like erythema. |
Q40069072 | Familial Mediterranean fever patients with hidradenitis suppurativa |
Q40592546 | Familial Mediterranean fever phenotype II in Greece. |
Q85334336 | Familial Mediterranean fever phenotype and MEFV variations |
Q101455559 | Familial Mediterranean fever phenotype progression into anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis:a case report |
Q37525673 | Familial Mediterranean fever presenting as fever of unknown origin in Korea. |
Q40559462 | Familial Mediterranean fever presenting as recurrent acute pelvic inflammatory disease |
Q40706808 | Familial Mediterranean fever presenting with massive cardiac tamponade. |
Q40333614 | Familial Mediterranean fever presenting with pulmonary embolism. |
Q40828647 | Familial Mediterranean fever presenting with recurrent severe myalgia |
Q46555625 | Familial Mediterranean fever protracted febrile myalgia in children: report of two cases |
Q40498315 | Familial Mediterranean fever responds well to infliximab: single case experience |
Q79364689 | Familial Mediterranean fever seems to be not uncommon in Greece |
Q40458427 | Familial Mediterranean fever successfully treated with etanercept. |
Q83876825 | Familial Mediterranean fever triggered by renal transplantation |
Q40156732 | Familial Mediterranean fever variant with repeated atypical skin eruptions |
Q78012731 | Familial Mediterranean fever with HLA B-27 positive ankylosing spondylitis in a young Armenian man |
Q40075708 | Familial Mediterranean fever with P369S/R408Q exon3 variant in pyrin presenting as symptoms of PFAPA. |
Q83000701 | Familial Mediterranean fever with a single MEFV mutation: can a deletion resulting in α-thalassemia be the cause? |
Q40154707 | Familial Mediterranean fever with a single MEFV mutation: comparison of rare and common mutations in a Turkish paediatric cohort |
Q37366257 | Familial Mediterranean fever with a single MEFV mutation: where is the second hit? |
Q40948213 | Familial Mediterranean fever with amyloidosis |
Q31028353 | Familial Mediterranean fever with amyloidosis associated with novel exon 2 mutation (S1791) of the MEFV gene |
Q40837935 | Familial Mediterranean fever with amyloidosis. Recent pathogenetic and therapeutic aspects |
Q37371701 | Familial Mediterranean fever with chronic ascites: a case report and a review of literature |
Q85710673 | Familial Mediterranean fever with convulsions: A rare association in a child |
Q40928491 | Familial Mediterranean fever with high serum unconjugated etiocholanolone level |
Q39382595 | Familial Mediterranean fever with massive recurrent ascites: a case report. |
Q40273987 | Familial Mediterranean fever with onset at 66 years of age. |
Q86419927 | Familial Mediterranean fever with onset in the 70s showing various neutrophilic dermatosis |
Q40611106 | Familial Mediterranean fever with pseudodominant inheritance |
Q40262132 | Familial Mediterranean fever with pulmonary manifestations alone; early diagnosis with genetic analysis |
Q92895200 | Familial Mediterranean fever with recurrent erysipelas-like erythema and myalgia: A case report |
Q40846878 | Familial Mediterranean fever with renal amyloidosis in a Gallacian family |
Q40890370 | Familial Mediterranean fever with temporomandibular joint arthritis |
Q35225591 | Familial Mediterranean fever without MEFV mutations: a case-control study |
Q40279262 | Familial Mediterranean fever without cardinal symptoms and role of genetic screening |
Q40241969 | Familial Mediterranean fever without fever as a cause of monoarthritis |
Q40926986 | Familial Mediterranean fever, amyloidosis and eclampsia (case report). |
Q40284226 | Familial Mediterranean fever, an amyloid thyroid goiter and an enlarged parathyroid gland |
Q40499446 | Familial Mediterranean fever, clinical and laboratory findings |
Q40855768 | Familial Mediterranean fever, complement, cryofibrinogen, colchicine (author's transl) |
Q24799138 | Familial Mediterranean fever, inflammation and nephrotic syndrome: fibrillary glomerulopathy and the M680I missense mutation |
Q39380468 | Familial Mediterranean fever, review of the literature. |
Q40533511 | Familial Mediterranean fever: 36 years to diagnosis. |
Q33785849 | Familial Mediterranean fever: An unusual disease enlightening the inflammation biology |
Q37296449 | Familial Mediterranean fever: An updated review |
Q52640843 | Familial Mediterranean fever: New insights into cancer immunoprevention? |
Q98188504 | Familial Mediterranean fever: Penetrance of the p.[Met694Val];[Glu148Gln] and p.[Met694Val];[=] genotypes |
Q97592402 | Familial Mediterranean fever: What associations to screen for? |
Q79379031 | Familial Mediterranean fever: a cause of periodic fever |
Q38142425 | Familial Mediterranean fever: a critical digest of the 2012-2013 literature. |
Q72667785 | Familial Mediterranean fever: a misnomer? |
Q40735533 | Familial Mediterranean fever: a report of 2 cases of Italian origin |
Q33925757 | Familial Mediterranean fever: abdominal imaging findings in 139 patients and review of the literature |
Q40545829 | Familial Mediterranean fever: an ancient hereditary disease |
Q40332490 | Familial Mediterranean fever: an association with non-alcoholic fatty liver disease |
Q30882352 | Familial Mediterranean fever: analysis of inheritance and current linkage data |
Q44228822 | Familial Mediterranean fever: attacks during isotretinoin treatment |
Q93371484 | Familial Mediterranean fever: breaking all the (genetic) rules |
Q40644173 | Familial Mediterranean fever: clastogenic plasma factors correlated with increased O2(-)--production by neutrophils |
Q38921330 | Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients |
Q36978762 | Familial Mediterranean fever: clinical, molecular and management advancements |
Q26751292 | Familial Mediterranean fever: current perspectives |
Q91149962 | Familial Mediterranean fever: different faces around the world |
Q45091232 | Familial Mediterranean fever: discovery of the responsible gene and the implications |
Q40621952 | Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosis |
Q77156415 | Familial Mediterranean fever: from inflammation to amyloidosis |
Q40723149 | Familial Mediterranean fever: from the clinical syndrome through the localization of the gene to the exploration of the biochemical anomaly |
Q74510628 | Familial Mediterranean fever: from the clinical syndrome to the cloning of the pyrin gene |
Q40201803 | Familial Mediterranean fever: genetic update |
Q36247836 | Familial Mediterranean fever: genotype-phenotype correlations in Japanese patients |
Q38961469 | Familial Mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel |
Q40620194 | Familial Mediterranean fever: high gene frequency and heterogeneous disease among an Israeli-Arab population. |
Q46727711 | Familial Mediterranean fever: is low mortality from tuberculosis a specific advantage for MEFV mutations carriers? Mortality from tuberculosis among Muslims, Jewish, French, Italian and Maltese patients in Tunis (Tunisia) in the first half of the 20 |
Q91149993 | Familial Mediterranean fever: misdiagnosis and diagnostic delay in Turkey |
Q34259213 | Familial Mediterranean fever: new aspects and prospects at the end of the millenium |
Q38033405 | Familial Mediterranean fever: new phenotypes. |
Q40815449 | Familial Mediterranean fever: no association of HLA with amyloidosis or colchicine treatment response |
Q40826069 | Familial Mediterranean fever: no linkage with HLA. |
Q40249218 | Familial Mediterranean fever: not to be missed |
Q92779870 | Familial Mediterranean fever: overview of pathogenesis, clinical features and management |
Q34088721 | Familial Mediterranean fever: prevalence, penetrance and genetic drift |
Q40607644 | Familial Mediterranean fever: report of a case |
Q40280568 | Familial Mediterranean fever: report of a large family, review of the literature, and discussion of the frequency of amyloidosis. |
Q40288715 | Familial Mediterranean fever: risk factors, causes of death, and prognosis in the colchicine era. |
Q40267495 | Familial Mediterranean fever: the first adult case in Korea |
Q41751840 | Familial Mediterranean fever: the genetics of inflammation |
Q100475681 | Familial Mediterranean fever: the molecular pathways from stress exposure to attacks |
Q43870675 | Familial Mediterranean fever: the potential for misdiagnosis of E148V using the E148Q usual RFLP detection method. |
Q40583682 | Familial Mediterranean fever: the segregation of four different mutations in 13 individuals from one inbred family: genotype-phenotype correlation and intrafamilial variability. |
Q38952330 | Familial Mediterranean fever: underlying defect clearer, but diagnostic problems persist |
Q53714230 | Familial Mediterranean fever; diagnosis, treatment, and complications. |
Q40320219 | Familial mediterranean Fever and hypercoagulability |
Q40443571 | Familial mediterranean Fever and renal disease |
Q39845776 | Familial mediterranean Fever as an emerging clinical model of atherogenesis associated with low-grade inflammation. |
Q37605663 | Familial mediterranean Fever in the world |
Q33674457 | Familial mediterranean Fever: a retrospective clinical and molecular study in the East of anatolia region of Turkey |
Q38727922 | Familial mediterranean Fever: diagnosing as early as 3 months of age. |
Q67405981 | Familial mediterranean fever (periodic peritonitis) |
Q34461208 | Familial mediterranean fever - a review and update |
Q40586138 | Familial mediterranean fever and Behçet's disease--are they associated? |
Q77376866 | Familial mediterranean fever and acute myocardial infarction secondary to coronary vasculitis |
Q94568692 | Familial mediterranean fever and immunoglobulin A nephropathy: A case report and review of the literature |
Q40392413 | Familial mediterranean fever and multiple sclerosis--a case report. |
Q46715713 | Familial mediterranean fever and pauciimmune renal vasculitis: the role of IL-1 blockade (Anakinra). |
Q80871452 | Familial mediterranean fever gene (MEVF) mutations in Crohn's disease in a Mediterranean area |
Q36431512 | Familial mediterranean fever in Arabs. |
Q40844106 | Familial mediterranean fever in Pondicherry (India). |
Q40827924 | Familial mediterranean fever in South India. |
Q40933300 | Familial mediterranean fever in Yugoslavia. Case history of 2 patients with autopsy findings in one and a review of 5 patients earlier reported |
Q40850513 | Familial mediterranean fever in a brother and sister treated with colchicine |
Q40310795 | Familial mediterranean fever in an Iranian patient with behcet disease |
Q79824018 | Familial mediterranean fever medicated with an herbal medicine in Japan |
Q68188634 | Familial mediterranean fever or the need for an early diagnosis |
Q87819274 | Familial mediterranean fever treated with anakinra: A case report |
Q79408946 | Familial mediterranean fever unusually coexisted in an ankylosing spondylitis patient. MEFV mutation has any role? |
Q84155012 | Familial mediterranean fever: a continuously challenging disease |
Q40400560 | Familial mediterranean fever: a diagnostic challenge in pregnancy |
Q38151758 | Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder |
Q40872826 | Familial mediterranean fever: a status report |
Q90111403 | Familial mediterranean fever: assessment of clinical manifestations, pregnancy, genetic mutational analyses, and disease severity in a national cohort |
Q34197548 | Familial mediterranean fever: revisiting an ancient disease |
Q40907156 | Familial paroxysmal polyserositis (familial Mediterranean fever); incidence of amyloidosis and mode of inheritance |
Q100511960 | Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor |
Q47579564 | Fatigue in familial Mediterranean fever and its relations with other clinical parameters. |
Q40153638 | Febrile seizures in children with familial Mediterranean fever: Coincidence or association? |
Q92850723 | Fecal calprotectin in children with familial Mediterranean fever in the attack-free period |
Q40340529 | Female reproductive dysfunction in familial Mediterranean fever patients with and without colchicine treatment |
Q40791781 | Fertility and obstetric history in patients with familial Mediterranean fever on long-term colchicine therapy |
Q40517969 | Fever and abdominal pain. A case of familial mediterranean fever |
Q40818708 | Fever as the only manifestation of recurrent familial Mediterranean fever |
Q40415799 | Fifth International Congress on Familial Mediterranean Fever and Systemic Autoinflammatory Diseases |
Q53350368 | First International Conference on familial Mediterranean fever, Jerusalem, Israel, September 7-11, 1997. |
Q89042889 | First autopsy case report of Familial Mediterranean fever in a Japanese man |
Q104489881 | First report of MEFV gene duplication in a patient with familial Mediterranean fever |
Q53703053 | Five Cases of Familial Mediterranean Fever in Japan: The Relationship with MEFV Mutations. |
Q33179732 | French Society for Human Genetics. "Genetics in Practice" Commission. Core scientific data of use in genetic counseling. Familial Mediterranean fever |
Q40286130 | Frequency of alterations in the MEFV gene and clinical signs in familial Mediterranean fever in Central Anatolia, Turkey |
Q40054594 | Frequency of familial Mediterranean fever (MEFV) gene mutations in patients with biopsy-proven primary glomerulonephritis. |
Q91300132 | Frequency of functional gastrointestinal disorders in children with familial Mediterranean fever |
Q40293532 | Frequency of juvenile fibromyalgia syndrome in children with familial Mediterranean fever: effects on depression and quality of life |
Q93067901 | Frequency, characteristics, and clinical determinants of 'prodrome' in familial Mediterranean fever patients |
Q40499431 | From familial Mediterranean fever to amyloidosis |
Q91702211 | Frosted Branch Angiitis Associated with Familial Mediterranean Fever |
Q37511881 | Frosted Branch Angiitis Secondary to Familial Mediterranean Fever Resembling Central Retinal Vein Occlusion |
Q44666643 | Fulminant acute pancreatitis in a patient with familial mediterranean fever on CAPD: what caused the pancreatitis? |
Q100683742 | Further Observations on the Occurrence of Protracted Febrile Myalgia of Familial Mediterranean Fever |
Q91385571 | Gastrointestinal evaluation in colchicine-treated familial Mediterranean fever patients with chronic abdominal pain: cases series |
Q97521393 | Gene-Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever |
Q40113544 | Generation of integration-free induced pluripotent stem cells from a patient with Familial Mediterranean Fever (FMF). |
Q40119619 | Genetic Profile of Patients with Familial Mediterranean Fever (FMF): Single Center Experience at King Hussein Medical Center (KHMC). |
Q55154827 | Genetic analysis of MEFV mutation negative familial Mediterranean fever for non-MEFV mutations is rarely effective. |
Q97676596 | Genetic and clinical characteristics associated with efficacy and retention rates of colchicine in Japanese patients with familial Mediterranean fever: a single-center observational study |
Q74097041 | Genetic counselling in familial Mediterranean fever: has the time come? |
Q38734577 | Genetic epidemiology of Familial Mediterranean Fever through integrative analysis of whole genome and exome sequences from Middle East and North Africa |
Q47784124 | Genetic heterogeneity in familial Mediterranean fever: comment on the article by Cazeneuve et al. |
Q33679129 | Genetic linkage study of familial Mediterranean fever (FMF) to 16p13.3 and evidence for genetic heterogeneity in the Turkish population |
Q34506303 | Genetic loss of murine pyrin, the Familial Mediterranean Fever protein, increases interleukin-1β levels |
Q40756662 | Genetic marker family studies in familial Mediterranean fever (FMF) in Armenians |
Q79926372 | Genetic predisposition of familial Mediterranean fever |
Q28268704 | Genetic risk factors of amyloidogenesis in familial Mediterranean fever |
Q40414589 | Genetic screening of familial Mediterranean fever mutations in the Palestinian population |
Q40624314 | Genetic screening of fourteen mutations in Jordanian familial Mediterranean fever patients |
Q40547742 | Genetic testing for familial Mediterranean fever in Austria by means of reverse-hybridization teststrips |
Q33507084 | Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis |
Q77840104 | Genetics of familial Mediterranean fever |
Q44893316 | Genetics of familial Mediterranean fever and its implications |
Q98775463 | Genome sequencing unveils mutational landscape of the familial Mediterranean fever: Potential implications of IL33/ST2 signalling |
Q64077628 | Genome-wide association study in Turkish and Iranian populations identify rare familial Mediterranean fever gene (MEFV) polymorphisms associated with ankylosing spondylitis |
Q97530654 | Genotype Mutations in Egyptian Children with Familial Mediterranean Fever: Clinical Profile, and Response to Colchicine |
Q34362949 | Genotype-phenotype correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical features between Japanese and Mediterranean populations |
Q40626660 | Genotype-phenotype correlation in a large group of Turkish patients with familial mediterranean fever: evidence for mutation-independent amyloidosis |
Q80914956 | Genotype-phenotype correlation in children with familial Mediterranean fever in a Turkish population |
Q40361971 | Genotype-phenotype correlation in patients with familial Mediterranean fever in East Anatolia (Turkey). |
Q77310619 | Genotype-phenotype relation and correlation in familial mediterranean fever |
Q40358324 | Genotype-phenotype studies in a large cohort of Armenian patients with familial Mediterranean fever suggest clinical disease with heterozygous MEFV mutations |
Q33678804 | Genotypic diagnosis of familial Mediterranean fever (FMF) using new microsatellite markers: example of two extensive non-Ashkenazi Jewish pedigrees |
Q35907740 | Global epidemiology of Familial Mediterranean fever mutations using population exome sequences. |
Q74532251 | Glomerular lesions other than amyloidosis in patients with familial Mediterranean fever |
Q89099154 | Glutathione-S-Transferase Variants are not Associated With Increased Carotid Intima-Media Thickness in Turkish Familial Mediterranean Fever Patients |
Q40468917 | Goats, germs, and fever: Are the pyrin mutations responsible for familial Mediterranean fever protective against Brucellosis? |
Q40591415 | Growth and IGF-1 levels of children with familial Mediterranean fever on colchicine treatment |
Q40408327 | Growth in familial mediterranean fever: effect of attack rate, genotype and colchicine treatment. |
Q99213704 | Gut Microbiota between Environment and Genetic Background in Familial Mediterranean Fever (FMF) |
Q40876899 | HLA-B27-Negative Sacroiliitis: A Manifestation of Familial Mediterranean Fever in Childhood |
Q37443875 | Hashimoto's Thyroiditis in a Child with Familial Mediterranean Fever: a Case Report |
Q40369628 | Health-related quality of life and its associations with mood condition in familial Mediterranean fever patients. |
Q37296512 | Heart rate variability in familial Mediterranean fever patients |
Q43816559 | Helicobacter pylori infection in Turkish children with familial Mediterranean fever: is it a cause of persistent inflammation? |
Q40626582 | Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. |
Q40901422 | Heredofamilial amyloidosis: incidence in familial Mediterranean fever: A report of two families |
Q40173210 | Heterozygote forms of familial Mediterranean fever can be manifested in adults as myofacial pain syndrome |
Q55417939 | Hidradenitis suppurativa and familial Mediterranean fever: a report of 6 cases and literature review. |
Q40167472 | High frequency of E148Q sequence variation in children with familial Mediterranean fever in southeast Turkey |
Q57593498 | High frequency of E148Q sequence variation in children with familial Mediterranean fever in southeast Turkey |
Q36903094 | High prevalence of spondyloarthritis and ankylosing spondylitis among familial Mediterranean fever patients and their first-degree relatives: further evidence for the connection |
Q92043197 | High prolidase levels in patients with Familial Mediterranean Fever (FMF) |
Q39491958 | Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups |
Q40216426 | Higher thrombin activatable fibrinolysis inhibitor levels are associated with inflammation in attack-free familial Mediterranean fever patients. |
Q79195480 | Histologic signs of inflammatory myopathy in familial Mediterranean fever |
Q40597139 | Homozygous ß-Thalassemia Associated with Familial Mediterranean Fever in a Turkish Patient |
Q55052692 | How long is the diagnosis of Familial Mediterranean Fever (FMF) delayed in a region where FMF is common in Turkey? |
Q97077826 | How to define disease severity accurately in patients with familial Mediterranean fever |
Q45790712 | Human foamy virus and familial Mediterranean fever in Japan |
Q71731386 | Hyperactive polymorphonuclear leucocytes migration in patients with Familial Mediterranean Fever |
Q42874660 | Hyperimmunoglobulinaemia D and periodic fever mimicking familial Mediterranean fever in the Mediterranean |
Q40662943 | Hyperimmunoglobulinemia D--a new periodic syndrome with features simulating familial Mediterranean fever |
Q80934425 | Hypermobility and fibromyalgia frequency in childhood familial Mediterranean fever |
Q55001856 | Hypohidrotic ectodermal dysplasia and Familial Mediterranean Fever in a child with recurrent episodes of hyperthermia. |
Q92427673 | IL-1 blockers together with colchicine may be administered as first line therapy in familial Mediterranean fever with amyloidosis |
Q47101226 | IL-18 serum concentration is continuously elevated in typical familial Mediterranean fever with M694I mutation and can distinguish atypical type |
Q86366215 | IL-18 serum concentration is markedly elevated in typical familial Mediterranean fever with M694I mutation and can distinguish it from atypical type |
Q90011996 | IL1-blocking therapy in colchicine-resistant familial Mediterranean fever |
Q89447042 | ILEOCOLONIC LYMPHONODULAR HYPERPLASIA IN CHILDREN; RELATED WITH VARIETY OF ETIOLOGIES RANGING FROM FOOD HYPERSENSITIVITY TO FAMILIAL MEDITERRANEAN FEVER |
Q81468658 | Identification of familial Mediterranean fever (FMF) in a Gypsy woman: a case report |
Q98647273 | Idiopathic multicentric Castleman disease with novel heterozygous Ile729Met mutation in exon 10 of familial Mediterranean fever gene |
Q40496667 | Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients |
Q37588405 | Idiopathic uveitis and familial mediterranean Fever: is there any relationship? |
Q38259418 | Immunological function of familial Mediterranean fever disease protein Pyrin |
Q40995392 | Immunological studies by the agar gel diffusion technic in familial Mediterranean fever (FMF). Preliminary report |
Q81450973 | Immunosuppressive treatment of AA amyloidosis of familial Mediterranean fever |
Q44658097 | Important Issues Concerning the Double-Blind Study of Anakinra in Familial Mediterranean Fever: Comment on the Article by Ben-Zvi et al. |
Q99579501 | Improvement of Liver Involvement in Familial Mediterranean Fever After the Introduction of Canakinumab: A Case Report |
Q92612424 | Improvement of MEFV gene variants classification to aid treatment decision making in familial Mediterranean fever |
Q89980137 | In Familial Mediterranean Fever, soluble TREM-1 plasma level is higher in case of amyloidosis |
Q93042007 | In familial Mediterranean fever, soluble TREM-1 plasma level is higher in case of amyloidosis |
Q40603219 | Incidence of familial Mediterranean fever (FMF) mutations among children of Mediterranean extraction with functional abdominal pain. |
Q40054869 | Incidence of sleep disturbances in patients with familial Mediterranean fever and the relation of sleep quality with disease activity |
Q93344783 | Increased Corneal Ectasia Risk in Patients with Familial Mediterranean Fever |
Q40254261 | Increased NLRP3-dependent interleukin 1β secretion in patients with familial Mediterranean fever: correlation with MEFV genotype |
Q40409956 | Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF? |
Q40259996 | Increased enthesopathy in patients with familial Mediterranean fever: evaluation with a new sonographic enthesitis index |
Q40323718 | Increased expression of exon 2 deleted MEFV transcript in familial Mediterranean fever patients |
Q40522274 | Increased frequency of familial Mediterranean fever in Central Anatolia, Turkey. |
Q39869833 | Increased frequency of familial Mediterranean fever in northern Turkey: a population-based study |
Q40481428 | Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect? |
Q98295585 | Increased frequency of sleep problems in children and adolescents with familial Mediterranean fever: The role of anxiety and depression |
Q36947461 | Increased levels of macrophage migration inhibitory factor in patients with familial mediterranean Fever |
Q86031115 | Increased mean platelet volume in patients with familial Mediterranean fever may not be a marker of atherosclerosis risk |
Q35561637 | Increased oxidative stress in patients with familial Mediterranean fever during attack period. |
Q69737586 | Increased procoagulant response of monocytes from patients with familial Mediterranean fever |
Q77228113 | Increased serum eosinophil cationic protein levels in familial Mediterranean fever |
Q40566165 | Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis |
Q46970620 | Indications and efficacy of canakinumab in Familial Mediterranean Fever: report of three cases |
Q40320997 | Infantile colitis as a novel presentation of familial Mediterranean fever responding to colchicine therapy |
Q40066745 | Infections After Renal Transplant in Recipients With Familial Mediterranean Fever: A Life-Threatening Issue |
Q100414952 | Infertility Causes and Pregnancy Outcome in Patients With Familial Mediterranean Fever (FMF) and Controls |
Q40429056 | Infiltrating perineal and scrotal inflammation: rare cutaneous manifestation of familial Mediterranean fever or acne inversa? |
Q73425651 | Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever |
Q40830387 | Inflammatory reaction in familial Mediterranean fever (FMF) before and with colchicine therapy. |
Q40484897 | Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association? |
Q44306308 | Infliximab therapy in a patient with familial Mediterranean fever and chronic hip arthritis |
Q40467292 | Infliximab treatment of Familial Mediterranean fever and its effect on secondary AA amyloidosis. |
Q43050119 | Interferon alfa in protracted arthritis of familial Mediterranean fever: a robust alternative for synovectomy |
Q37833330 | Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature |
Q40176934 | Interleukin-1 targeting treatment in familial Mediterranean fever: an experience of pediatric patients |
Q40493424 | Interleukin-6 (IL-6) -174 G/C polymorphism in familial Mediterranean fever patients with and without amyloidosis. |
Q95455775 | Intermediate uveitis associated with familial Mediterranean fever |
Q90845584 | Intermittent right bundle branch block in a child with familial mediterranean fever |
Q38977041 | International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome |
Q24187197 | Interventions for reducing inflammation in familial Mediterranean fever |
Q24201537 | Interventions for reducing inflammation in familial Mediterranean fever |
Q57688726 | Interventions for reducing inflammation in familial Mediterranean fever |
Q91672500 | Intima media thickness as an early predictor of atherosclerosis in Egyptian children with familial Mediterranean fever |
Q40182868 | Intrauterine device may trigger typical attacks of familial Mediterranean fever: a case report |
Q40542352 | Intravenous colchicine for treatment of patients with familial Mediterranean fever unresponsive to oral colchicine. |
Q84612764 | Intravenous colchicine treatment for six months: adjunctive therapy in familial Mediterranean fever (FMF) unresponsive to oral colchicine |
Q37680308 | Investigation of the arterial stiffness and associated factors in patients with familial Mediterranean fever |
Q54895973 | Is Familial Mediterranean Fever a clinical diagnosis? Results of a field survey. |
Q40452547 | Is Familial Mediterranean Fever a thrombotic disease or not? |
Q82758879 | Is MEFV P706 polymorphism important in familial Mediterranean fever patients? |
Q40281721 | Is familial Mediterranean fever (FMF) common in patients with negative appendectomy? |
Q40382382 | Is familial Mediterranean fever a possible cofactor for Budd-Chiari syndrome? |
Q35573526 | Is hyperbilirubinemia a component or just a coincidence of familial mediterranean fever: a case report and review of the literature |
Q78350853 | Is there a heterozygote advantage for familial Mediterranean fever carriers against tuberculosis infections: speculations remain? |
Q40424170 | Is there an association between familial Mediterranean fever and celiac disease? |
Q40058789 | Is there any difference regarding atopy between children with familial Mediterranean fever and healthy controls? |
Q84903748 | Isolated myositis as a sole presentation of familial Mediterranean fever |
Q93170048 | Isolated parenchymal pulmonary presentation of familial Mediterranean fever |
Q40369559 | Isolated recurrent pleuritis revealing familial mediterranean Fever in adulthood |
Q28512000 | Isolation, genomic organization, and expression analysis of the mouse and rat homologs of MEFV, the gene for familial mediterranean fever |
Q40107214 | Jejunoileitis in Adult-onset Familial Mediterranean Fever in Japan |
Q40453746 | Juvenile psoriatic arthritis carrying familial Mediterranean fever gene mutations in a 14-year-old Turkish girl. |
Q64884960 | Kawasaki disease and familial mediterranean fever gene mutations, is there any link? |
Q90806133 | Kawasaki disease triggered by EBV virus in a child with Familial Mediterranean Fever |
Q40856602 | Kidney allograft in familial Mediterranean fever a case report and review of the literature (author's transl) |
Q36306285 | Killer Cell Immunoglobulin-Like Receptor (KIR) Genotype Distribution in Familial Mediterranean Fever (FMF) Patients |
Q55668885 | LPS-induced gene expression of inflammation-related genes in neutrophils from familial Mediterranean fever patients. |
Q45115587 | Lack of association between familial Mediterranean fever and angiotensin converting enzyme gene polymorphism |
Q48114554 | Lack of clear and univocal genotype-phenotype correlation in Familial Mediterranean Fever patients: A systematic review |
Q89099312 | Lack of the Association of the PTPN22 C1858T Gene Polymorphism With Susceptibility to Familial Mediterranean Fever |
Q36264671 | Lactobacillus acidophilus INMIA 9602 Er-2 strain 317/402 probiotic regulates growth of commensal Escherichia coli in gut microbiota of familial Mediterranean fever disease subjects |
Q40066735 | Late Diagnosis of E148Q Mutation-Positive Familial Mediterranean Fever in a Kidney Transplant Patient With Fever of Unknown Origin: A Case Report |
Q72437372 | Late histological recurrence of familial Mediterranean fever amyloidosis after renal transplantation |
Q77362362 | Late occurrence of chronic renal failure in familial mediterranean fever after 20 years of colchicine treatment |
Q40210433 | Late onset of Crohn’s disease in familial Mediterranean fever: the necessity of anti-TNF treatment |
Q57588203 | Late presentation of familial Mediterranean fever associated with P369S/R408Q variant in the MEFV gene |
Q40355252 | Late presentation of familial mediterranean fever: a case report |
Q47109776 | Late ventricular potentials in familial Mediterranean fever with and without AA amyloidosis |
Q58030459 | Late-Onset Familial Mediterranean Fever: An Atypical Presentation of Dermatologic Interest |
Q39507963 | Late-onset familial Mediterranean fever (FMF): a subset with distinct clinical, demographic, and molecular genetic characteristics |
Q92211592 | Late-onset familial Mediterranean fever in Japan |
Q41950027 | Letter to the Editor - Arrhythmic risk evaluation in familial mediterranean fever: the role of electrocardiographic and echocardiographic parameters |
Q96822731 | Letter to the Editor: Coexistence of Autoimmune Lymphoproliferative Syndrome and Familial Mediterranean Fever |
Q69742727 | Letter: Colchicine for familial Mediterranean fever (periodic peritonitis) |
Q40906535 | Letter: Colchicine for familial Mediterranean fever: possible adverse effects |
Q40897996 | Letter: Treatment of periodic disease (familial Mediterranean fever) by colchicine |
Q82224649 | Leucopenia resoluted with colchicine in familial mediterranean Fever |
Q38096482 | Leukopenia in familial Mediterranean fever: case series and literature review with special emphasis on pathogenesis |
Q40522265 | Levels of interleukin-6 (IL-6) and its soluble receptor (sIL-6R) in familial Mediterranean fever (FMF) patients and their first degree relatives. |
Q35881476 | Linkage disequilibrium mapping places the gene causing familial Mediterranean fever close to D16S246. |
Q90271484 | Lipid disorders in Familial Mediterranean Fever patients: Is inflammation the only cause? |
Q88384976 | Lipid profile and atherogenic indices and their association with platelet indices in familial Mediterranean fever |
Q69537923 | Liver sinusoidal dilatation in familial Mediterranean fever |
Q40041154 | Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report. |
Q40624522 | Living with a child with familial Mediterranean fever: does it affect the quality of life of the parents? |
Q71380967 | Localization of the familial Mediterranean fever gene (FMF) to a 250-kb interval in non-Ashkenazi Jewish founder haplotypes. The French FMF Consortium |
Q101237937 | Localized conjunctival amyloidosis due to familial Mediterranean fever |
Q36845638 | Long chain fatty acid (Lcfa) abnormalities in hyper Igd syndrome (Hids) and Familial Mediterranean Fever (Fmf): new insight into heritable periodic fevers |
Q100760255 | Long term administration of tocilizumab improves renal amyloid A (AA) amyloidosis deposition in Familial Mediterranean fever |
Q92543210 | Long-term Results of Kidney Transplantation in Patients With Familial Mediterranean Fever and Amyloidosis |
Q40761955 | Long-term colchicine prophylaxis in children with familial Mediterranean fever (recurrent hereditary polyserositis). |
Q67692370 | Long-term colchicine prophylaxis in familial Mediterranean fever |
Q90580498 | Long-term effectiveness and safety of canakinumab in pediatric familial Mediterranean fever patients |
Q96639775 | Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial |
Q54918423 | Long-term familial Mediterranean fever remission on successful hepatitis C virus treatment in a patient not responding to colchicine: a case report. |
Q40518296 | Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience |
Q40225728 | Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience. |
Q41922325 | Longitudinal analysis of serum interleukin-18 in patients with familial Mediterranean fever carrying MEFV mutations in exon 10. |
Q40988256 | Low-fat diet in familial Mediterranean fever; a therapeutic trial |
Q77484668 | M680I(Arm2)/M694V(Med) mutations in a patient with familial Mediterranean fever and polyarteritis nodosa |
Q34990527 | MEFV Gene Profile in Northwest of Iran, Twelve Common MEFV Gene Mutations Analysis in 216 Patients with Familial Mediterranean Fever |
Q40082582 | MEFV and SAA1 genotype associations with clinical features of familial Mediterranean fever and amyloidosis in Armenia |
Q40373455 | MEFV gene compound heterozygous mutations in familial Mediterranean fever phenotype: a retrospective clinical and molecular study |
Q55001895 | MEFV gene methylation pattern analysis in familial Mediterranean fever patients with altered expression levels. |
Q40317284 | MEFV gene mutation spectrum in familial Mediterranean fever (FMF) : a single center study in the Aegean region of Turkey |
Q37597571 | MEFV gene mutations and cardiac phenotype in children with familial Mediterranean fever: a cohort study. |
Q40572126 | MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: a retrospective clinicopathological and molecular study |
Q40447308 | MEFV gene mutations spectrum among Lebanese patients referred for Familial Mediterranean Fever work-up: experience of a major tertiary care center. |
Q35000051 | MEFV heterogeneity in Turkish Familial Mediterranean Fever patients |
Q58284002 | MEFV mutation analysis in Turkish familial Mediterranean fever patients with amyloidosis |
Q58273510 | MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever |
Q40425023 | MEFV mutation analysis of familial Mediterranean fever in Japan. |
Q36048204 | MEFV mutation carriers and diseases other than familial Mediterranean fever: proved and non-proved associations; putative biological advantage |
Q104467444 | MEFV mutation frequencies in a Turkish cohort with low prevalence of familial Mediterranean fever |
Q38987311 | MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations |
Q40542108 | MEFV mutations in familial Mediterranean fever: association of M694V homozygosity with arthritis |
Q40618094 | MEFV mutations in multiplex families with familial Mediterranean fever: is a particular genotype necessary for amyloidosis? |
Q40389450 | MEFV mutations in patients with Familial Mediterranean Fever from the Aegean region of Turkey. |
Q40432693 | MEFV mutations in patients with familial Mediterranean fever in the Black Sea region of Turkey: Samsun experience [corrected]. |
Q34390765 | MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications |
Q53780533 | Magnetic resonance imaging features of Familial Mediterranean Fever associated spondyloarthritis. |
Q35058731 | Male sex coupled with articular manifestations cause a 4-fold increase in susceptibility to amyloidosis in patients with familial Mediterranean fever homozygous for the M694V-MEFV mutation |
Q36566547 | Management of familial Mediterranean fever by colchicine does not normalize the altered profile of microbial long chain fatty acids in the human metabolome |
Q40732764 | Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. |
Q33967153 | Mapping of the Familial Mediterranean Fever Gene to Chromosome 16 |
Q40184614 | Massive proteinuria and acute glomerulonephritis picture in a patient with Familial Mediterranean fever and E148Q mutation |
Q40135318 | Mean Platelet Volume and Splenomegaly as Useful Markers of Subclinical Activity in Egyptian Children with Familial Mediterranean Fever: A Cross-Sectional Study |
Q40275762 | Mean platelet volume and β-thromboglobulin levels in familial Mediterranean fever: effect of colchicine use? |
Q90002235 | Medical Cannabis in Treatment of Resistant Familial Mediterranean Fever |
Q40241017 | Mediterranean Fever gene analysis in the azeri turk population with familial mediterranean Fever: evidence for new mutations associated with disease |
Q34920569 | Melatonin and its day and night rhythm of alterations in familial mediterranean Fever: a brief research letter |
Q100535200 | Menorrhagia due to uterine amyloidosis in familial Mediterranean fever: case-based review |
Q40298684 | Mesangial proliferative glomerulonephritis in familial Mediterranean fever patient with E148Q mutation: the first case report. |
Q40161980 | Mesothelioma and familial Mediterranean fever: A relationship? |
Q96023693 | Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review |
Q72580096 | Metaraminol provocation test for familial Mediterranean fever |
Q44149130 | Metaraminol provocation test in a case of familial Mediterranean fever |
Q47222575 | MicroRNA-204-3p inhibits lipopolysaccharide-induced cytokines in familial Mediterranean fever via the phosphoinositide 3-kinase γ pathway |
Q80607935 | Microalbuminuria in the course of familial Mediterranean fever |
Q40277086 | Misdiagnosis of familial Mediterranean fever in patients with Anderson-Fabry disease |
Q99211766 | Misleading symptoms of hereditary angioedema type II mimicking familial mediterranean fever |
Q91218480 | Mitochondrial DNA copy number alterations in familial mediterranean fever patients |
Q57831046 | Molecular Diagnosis of Familial Mediterranean Fever |
Q64237026 | Molecular Patterns of MEFV Gene Mutations in Egyptian Patients with Familial Mediterranean Fever: A Retrospective Cohort Study |
Q73337492 | Molecular diagnosis of familial Mediterranean fever |
Q84767497 | Molecular evaluation of 458 patients referred with a clinical diagnosis of familial Mediterranean fever in Scandinavia |
Q28139395 | Molecular genetic testing for familial Mediterranean fever |
Q91825863 | Monocyte-derived dendritic cells display a highly activated phenotype and altered function in patients with familial Mediterranean fever |
Q40711997 | Monosymptomatic familial Mediterranean fever as the cause of fever of unknown origin |
Q37068967 | Mortality risk factors associated with familial Mediterranean fever among a cohort of 1.25 million adolescents |
Q36742462 | Morvan's syndrome and myasthenia gravis related to familial Mediterranean fever gene mutations |
Q36838115 | Multiple Serum Cytokine Profiling to Identify Combinational Diagnostic Biomarkers in Attacks of Familial Mediterranean Fever |
Q89628547 | Multiple pelvic cysts in a patient with familial Mediterranean fever: Benign cystic mesothelioma |
Q40409087 | Multiple sclerosis and familial Mediterranean fever: a case report |
Q40429870 | Multiple visceral hematomas in a child with familial Mediterranean fever: polyarteritis nodosa |
Q40500360 | Multiplex molecular diagnosis of MEFV mutations in patients with familial Mediterranean fever by LightCycler real-time PCR. |
Q72706423 | Muscle ultrasound evaluation of patients with familial Mediterranean fever complicated by myalgia |
Q59336394 | Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: Data from a multicenter, prospective national cohort study in Japan |
Q34389277 | Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. |
Q40599425 | Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population |
Q40478142 | Mutational analysis of the PRYSPRY domain of pyrin and implications for familial mediterranean fever (FMF). |
Q40430119 | Mutations in the familial Mediterranean fever gene of patients with IgA nephropathy and other forms of glomerulonephritis |
Q40550727 | Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? |
Q47853652 | Myalgia as a symptom of familial Mediterranean fever in children |
Q40287488 | Myocardial infarction in patients with familial Mediterranean fever and cardiac lesions |
Q40238621 | Myositis in a patient with familial Mediterranean fever and spondyloarthritis successfully treated with anakinra |
Q90589005 | Necessity of Utilizing Physiological Glucocorticoids for Managing Familial Mediterranean Fever |
Q80934427 | Necrotizing crescentic glomerulonephritis with granulomatous vasculitis in a patient with familial Mediterranean fever and renal amyloidosis |
Q90228204 | Neonatal onset familial Mediterranean fever |
Q50063174 | Neonatal ulcerative colitis associated with Familial Mediterranean fever: a case report |
Q40087848 | Neurological Manifestations in Familial Mediterranean Fever: Results of 22 Children from a Reference Center in Kayseri, an Urban Area in Central Anatolia, Turkey |
Q89538654 | Neurological Manifestations in Familial Mediterranean Fever: a Genotype-Phenotype Correlation Study |
Q40256535 | Neutrophil F-actin dynamics in Familial Mediterranean Fever: the unequal effect of colchicine on activated neutrophils. |
Q40539435 | Neutrophil adhesion molecule expression in familial Mediterranean fever: discordance between the intravascular regulation of beta2 integrin and L-selectin expression in acute attack |
Q40167665 | Neutrophil-lymphocyte ratio in children with familial Mediterranean fever: Original article |
Q90566835 | Next-generation screening of a panel of genes associated with periodic fever syndromes in patients with Familial Mediterranean Fever and their clinical characteristics |
Q100474364 | Next-generation sequencing of the whole MEFV gene in Japanese patients with familial Mediterranean fever: a case-control association study |
Q40898307 | Nomenclature: Familial Mediterranean Fever and Periodic Peritonitis |
Q90512561 | Non-amyloid liver involvement in familial Mediterranean fever: a systematic literature review |
Q38374152 | Non-canonical manifestations of familial Mediterranean fever: a changing paradigm |
Q38905942 | Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). |
Q35553949 | Non-isotopic RNase cleavage assay for mutation detection in MEFV, the gene responsible for familial Mediterranean fever, in a cohort of Greek patients |
Q40211562 | Non-response to colchicine in familial Mediterranean fever should be identified accurately |
Q40262173 | Nonalcoholic fatty liver disease and familial Mediterranean fever: are they related? |
Q39186964 | Normal Heart Rate Variability in Colchicine-Resistant Familial Mediterranean Fever Patients. |
Q40289409 | Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF). |
Q38946784 | Normal arterial stiffness in familial Mediterranean fever: evidence for a possible cardiovascular protective role of colchicine |
Q40326106 | Normal autonomic nervous system responses in uncomplicated familial Mediterranean fever: a comparative case-control study |
Q91639388 | Novel Deleterious nsSNPs within MEFV Gene that Could Be Used as Diagnostic Markers to Predict Hereditary Familial Mediterranean Fever: Using Bioinformatics Analysis |
Q38122566 | Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics |
Q40404114 | Nutcracker syndrome in a child with familial Mediterranean fever (FMF) disease: renal ultrastructural features |
Q90654810 | On demand use of anakinra for attacks of familial Mediterranean fever (FMF) |
Q48277726 | One novel and two uncommon MEFV mutations in Japanese patients with familial Mediterranean fever: a clinicogenetic study |
Q40224913 | Ophthalmic manifestations in familial Mediterranean fever: a case series of 6 patients |
Q94559344 | Optical coherence tomography-angiographic vascular densities in Familial Mediterranean Fever (FMF) Patients with M694V Mutations |
Q40252226 | Oral health and oral quality of life in inactive patients with familial Mediterranean fever without amyloidosis |
Q90124429 | Orthopedic and orthodontic management in a patient with DiGeorge Syndrome and Familial Mediterranean Fever: A case report |
Q59298752 | Our successful surgical coronary revascularization in a case with familial Mediterranean fever |
Q92543214 | Outcomes of Canakinumab Treatment in Recipients of Kidney Transplant With Familial Mediterranean Fever: A Case Series |
Q40168179 | Overlap of familial Mediterranean fever and hyper-IgD syndrome in an Arabic kindred |
Q40206941 | Overlap syndrome between Familial Mediterranean fever and tumor necrosis factor receptor-associated periodic syndrome in a lupus patient |
Q40713770 | Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. |
Q40518828 | Oxidative stress status in familial Mediterranean fever with or without proteinuria |
Q34102054 | P wave dispersion and QT dispersion in adult Turkish migrants with familial mediterranean fever living in Germany |
Q40544706 | PFAPA syndrome mimicking familial Mediterranean fever: report of a Turkish child |
Q46103088 | PReS-FINAL-2197: Teenage boy suffering from diabetes mellitus type 1 and heterozygous Familial Mediterranean Fever: a case report |
Q55531569 | PReS-FINAL-2207: Results from a multicenter international registry of Familial Mediterranean Fever: validation of the new set of pediatric diagnostic criteria. |
Q55540832 | PReS-FINAL-2214: Validation of new pediatric criteria in diagnosis of Familial Mediterranean Fever in children. |
Q47093557 | PReS-FINAL-2215: Genotype-phenotype correlations in children with Familial Mediterranean Fever in Germany |
Q55537139 | PReS-FINAL-2226: Assessment of autonomic functions in children with Familial Mediterranean Fever by using heart rate variability measurements. |
Q46708228 | PReS-FINAL-2242: Familial Mediterranean Fever - first experiences in Slovakia |
Q40239441 | Patient management and the association of less common familial Mediterranean fever symptoms with other disorders. |
Q40820650 | Patient with familial Mediterranean fever and amyloidosis |
Q91330872 | Pattern and diagnostic evaluation of systemic autoinflammatory diseases other than familial Mediterranean fever among Arab children: a multicenter study from the Pediatric Rheumatology Arab Group (PRAG) |
Q72634048 | Pattern of proteinuria in patients with renal amyloidosis secondary to familial Mediterranean fever |
Q90454142 | Penoscrotal rash due to familial Mediterranean fever |
Q40130919 | Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International Registry |
Q90915033 | Performance of Tel-Hashomer, Livneh, pediatric and new Eurofever/PRINTO classification criteria for familial Mediterranean fever in a referral center |
Q92189886 | Performance of recently proposed periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome criteria in a region endemic for familial Mediterranean fever |
Q100417913 | Performance of the new Eurofever/PRINTO classification criteria in Familial Mediterranean fever patients with a single exon 10 mutation in childhood |
Q41030457 | Periarteritis nodosa and periodic disease |
Q40964705 | Periarteritis nodosa in a patient with familial Mediterranean fever |
Q40844842 | Pericardial disease in familial Mediterranean fever: an echocardiographic study |
Q37852153 | Periodic Peritonitis due to Familial Mediterranean Fever in a Patient with Systemic Lupus Erythematosus |
Q39667564 | Periodic disease, recurrent polyserositis, familial Mediterranean fever, or simply 'FMF'. |
Q81517358 | Periodic fever and apoptosis of accumulated neutrophils in familial mediterranean fever: comment on the article by Touitou et al |
Q75249803 | Periodic fever in infants: familial Mediterranean fever only? |
Q40406060 | Periodontal disease in patients with familial Mediterranean fever: from inflammation to amyloidosis |
Q81345066 | Peritoneal amyloidosis caused by Familial Mediterranean Fever |
Q85854641 | Pharmacokinetics of colchicine in pediatric and adult patients with familial Mediterranean fever |
Q34395824 | Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update. |
Q40494365 | Pharmacological modulation of phagocytosis of granulocytes and monocytes in patients with familial Mediterranean fever |
Q38066272 | Phenotype 2 familial mediterranean fever: evaluation of 22 case series and review of the literature on phenotype 2 FMF. |
Q34086383 | Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features |
Q38971609 | Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). |
Q40639120 | Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis |
Q38866091 | Phenotype-genotype updates from familial Mediterranean fever database registry of Mansoura University Children' Hospital, Mansoura, Egypt |
Q40684620 | Photo quiz. Familial Mediterranean fever (FMF) |
Q40319723 | Pitfalls in familial mediterranean fever: acute intestinal strangulation/obstruction due to primary adhesions |
Q96817012 | Plague as a cause for familial Mediterranean fever |
Q40846517 | Plasma colchicine concentration in patients with recurrent polyserositis (familial Mediterranean fever) on long-term prophylaxis |
Q40545793 | Plasma nitric oxide level in familial Mediterranean fever and its modulations by Immuno-Guard |
Q37721227 | Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra--case report and review |
Q40336387 | Polyarteritis nodosa and Henoch-Schönlein purpura nephritis in a child with familial Mediterranean fever: a case report |
Q38356752 | Polyarteritis nodosa and familial Mediterranean fever: a report of 2 cases and review of the literature |
Q90238558 | Polyarteritis nodosa in case of familial Mediterranean fever |
Q40608723 | Polyarteritis nodosa in patients with Familial Mediterranean Fever (FMF): a concomitant disease or a feature of FMF? |
Q40699398 | Polyarteritis nodosa type vasculitis in a patient with familial Mediterranean fever treated with cyclosporin A. |
Q36849254 | Population genetics of familial Mediterranean fever: a review. |
Q46567539 | Possible correlation between reversible and irreversible lesions in familial Mediterranean fever, soluble Fas, and C5a inhibitor activity: comment on the letter by Yasui and Yamazaki |
Q40414353 | Possible familial Mediterranean fever in a Caucasian patient with systemic lupus erythematosus |
Q90778762 | Posterior Scleritis in Familial Mediterranean Fever |
Q92078401 | Posterior Segment Ocular Parameters in Children with Familial Mediterranean Fever |
Q92160149 | Potential of miRNAs to predict and treat inflammation from the perspective of Familial Mediterranean Fever |
Q90735960 | Potential role of pyrin, the protein mutated in familial Mediterranean fever, during inflammatory cell migration |
Q98303771 | Predictors of persistent inflammation in familial Mediterranean fever and association with damage |
Q40364981 | Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified? |
Q102323295 | Prescription of interleukin-1 inhibitors in a French adult cohort of familial Mediterranean fever |
Q40388867 | Presentation of familial Mediterranean fever in a heterozygous MEFV mutation triggered by immunosuppressive therapy for myelodysplastic syndrome |
Q40546130 | Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura |
Q36021488 | Prevalence and significance of mutations in the familial Mediterranean fever gene in patients with Crohn's disease |
Q40595351 | Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin Q148. |
Q40108750 | Prevalence of Fabry Disease in Familial Mediterranean Fever Patients from Central Anatolia of Turkey |
Q91715174 | Prevalence of MEFV gene mutations in a large cohort of patients with suspected familial Mediterranean fever in Central Anatolia |
Q89799225 | Prevalence of Nonalcoholic Fatty Liver Disease in Familial Mediterranean Fever |
Q78000693 | Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study |
Q39482483 | Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. |
Q40418624 | Prevalence of known mutations in the familial Mediterranean fever gene (MEFV) in various carrier screening populations |
Q40196694 | Prevalence of periodontal disease in patients with Familial Mediterranean Fever: a cohort study from central Turkey |
Q40378286 | Prevention of amyloidosis in familial Mediterranean fever with colchicine: a case-control study in Armenia |
Q67765868 | Primary gastric lymphoma occurring in familial Mediterranean fever |
Q89576439 | Probiotic Lactobacillus acidophilus Strain INMIA 9602 Er 317/402 Administration Reduces the Numbers of Candida albicans and Abundance of Enterobacteria in the Gut Microbiota of Familial Mediterranean Fever Patients |
Q40876201 | Prolonged remission with colchicine in a case of familial mediterranean fever |
Q35574093 | Proteinuria-associated nutcracker syndrome: an amyloid-negative familial Mediterranean fever patient |
Q54622293 | Protracted Myalgia Syndrome as the Presenting Sign of Familial Mediterranean Fever: Is Group A β-Hemolytic Streptococcus Infection a Causative Factor? |
Q40644184 | Protracted arthritis of familial Mediterranean fever (an unusual complication). |
Q40626975 | Protracted familial Mediterranean fever arthritis |
Q40454355 | Protracted familial mediterranean fever arthritis presenting as septic arthritis. |
Q57183822 | Protracted febrile myalgia as a challenging manifestation of familial Mediterranean fever: case-based review |
Q40101881 | Protracted febrile myalgia in a patient with Familial Mediterranean Fever and Ankylosing Spondylitis |
Q36976066 | Protracted febrile myalgia in children and young adults with familial Mediterranean fever: analysis of 15 patients and suggested criteria for working diagnosis. |
Q84770914 | Protracted febrile myalgia in two children with familial Mediterranean fever |
Q99208049 | Protracted febrile myalgia syndrome as the first manifestation of familial Mediterranean fever in children: case-based review |
Q47869322 | Protracted febrile myalgia syndrome in a patient with familial Mediterranean fever homozygous for the E148Q mutation |
Q85089107 | Protracted synovitis without systemic manifestations in familial Mediterranean fever (FMF) |
Q92381057 | Pseudodominance of autoinflammatory disease in a single Turkish family explained by co-inheritance of haploinsufficiency of A20 and familial Mediterranean fever |
Q40745020 | Pulmonary hypertension and familial Mediterranean fever: a previously unrecognized association |
Q54445026 | Pulmonary hypertension in familial Mediterranean fever: consequence or coincidence? |
Q24655872 | Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway |
Q90558373 | Pyrin dephosphorylation is sufficient to trigger inflammasome activation in familial Mediterranean fever patients |
Q74453988 | Pyrin/marenostrin mutations in familial Mediterranean fever |
Q40298492 | QT interval variability in familial Mediterranean fever: a study in colchicine-responsive and colchicine-resistant patients |
Q40262692 | Quality of life in adult patients with Familial Mediterranean fever living in Germany or Turkey compared to healthy subjects: a study evaluating the effect of disease severity and country of residence |
Q45744994 | Quality of life of school-age children with Familial Mediterranean fever: a preliminary study |
Q91275776 | RAC1 expression and role in IL-1β production and oxidative stress generation in familial Mediterranean fever (FMF) patients |
Q100301120 | Rapid Diagnosis of Meningococcal Meningitis in a Patient With Familial Mediterranean Fever by the FilmArray Meningitis/Encephalitis Panel: A Case Report |
Q33955559 | Rapidly progressive Creutzfeldt-Jakob disease in patients with Familial Mediterranean Fever |
Q43459672 | Rapidly progressive glomerulonephritis in a patient with familial Mediterranean fever and renal amyloidosis. |
Q40133572 | Rare disorders can be an underlying cause of cyclic vomiting: Familial Mediterranean fever, Helicobacter pylori gastritis, and cavernous transformation of the portal vein. |
Q44039184 | Reactive amyloidosis and familial Mediterranean fever (FMF). |
Q40934555 | Record survival of siblings with familial Mediterranean fever, phenotypes 1 and 2. |
Q40856598 | Recurrence of amyloidosis on the kidney transplant despite colchicine therapy in a patient with familial Mediterranean fever (author's transl) |
Q40734868 | Recurrent abdominal pain and fever: familial Mediterranean fever |
Q68615917 | Recurrent bilateral panuveitis and rhegmatogenous retinal detachment in a patient with familial Mediterranean fever |
Q40398137 | Recurrent bullous lesions associated with familial Mediterranean fever: a case report. |
Q96587271 | Recurrent debilitating calf pain associated with fasciitis in Familial Mediterranean fever and response to canacinumab |
Q77487546 | Recurrent episodic fever. A presenting feature of familial Mediterranean fever |
Q38952403 | Recurrent hereditary polyserositis or familial Mediterranean fever: An overview. |
Q40643902 | Recurrent hydrocele in a patient with familial mediterranean fever |
Q74840833 | Recurrent hyperbilirubinaemia, a feature of familial Mediterranean fever: report of a child and review of the literature |
Q73419561 | Recurrent pericarditis as a manifestation of familial Mediterranean fever |
Q40684828 | Recurrent pericarditis in familial Mediterranean fever |
Q73078323 | Recurrent pericarditis in familial Mediterranean fever |
Q47708699 | Recurrent pleural effusion is an important diagnostic clue to distinguish familial Mediterranean fever from Behçet's disease |
Q40417970 | Recurrent pleurisy as sole manifestation of familial Mediterranean fever |
Q100437886 | Recurrent pleuritis with pleural thickening as the manifestation of familial Mediterranean fever |
Q38592680 | Recurrent polyserositis (familial Mediterranean fever) in a Japanese |
Q69647142 | Recurrent pulmonary atelectasis as a manifestation of familial Mediterranean fever |
Q90272966 | Red Cell Distribution Width (RDW) as a marker of Subclinical Inflammation in Children with Familial Mediterranean Fever |
Q28208176 | Reduced MEFV messenger RNA expression in patients with familial Mediterranean fever |
Q40911395 | Reduction in Sperm Output by Febrile Attacks of Familial Mediterranean Fever: A Case Report |
Q35194870 | Refined mapping of the gene causing familial Mediterranean fever, by linkage and homozygosity studies |
Q40715857 | Regional mapping of the gene for familial Mediterranean fever on human chromosome 16p13. |
Q72295451 | Regression of amyloidosis with colchicine in familial Mediterranean fever in an Ashkenazi patient |
Q73387226 | Regression of nephrotic syndrome due to amyloidosis secondary to familial mediterranean fever following colchicine treatment |
Q73011007 | Regression of nephrotic syndrome in amyloidosis of familial mediterranean fever following colchicine treatment |
Q40774917 | Regression of nephrotic syndrome in amyloidosis secondary to familial Mediterranean fever during maintenance therapy using colchicine |
Q33365090 | Regulated in development and DNA damage responses 1 (REDD1) links stress with IL-1β-mediated familial Mediterranean fever attack through autophagy-driven neutrophil extracellular traps. |
Q28180120 | Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product |
Q82692312 | Relapsing polychondritis in a patient with familial Mediterranean fever and amyloidosis |
Q40495649 | Relationship between HLA-DR, HLA-DQ alleles and MEFV gene mutations in familial Mediterranean fever (FMF) patients |
Q91074711 | Relationship between Metabolic Syndrome and Uric Acid Levels in Patients with Familial Mediterranean Fever |
Q40229718 | Relationship between response to colchicine treatment and MDR1 polymorphism in familial Mediterranean fever patients |
Q33773150 | Relationship between serum interleukin-1beta levels and acute phase response proteins in patients with familial Mediterranean fever |
Q40463205 | Relationship of Tel Hashomer criteria and Mediterranean fever gene mutations in a cohort of Turkish familial Mediterranean fever patients. |
Q40253253 | Relationship of paraoxonase-1, malondialdehyde and mean platelet volume with markers of atherosclerosis in familial Mediterranean fever: an observational study |
Q64947385 | Remission of nephrotic syndrome in amyloidosis of familial Mediterranean fever following colchicine treatment. |
Q35601961 | Remission of progressive renal failure in familial Mediterranean fever during colchicine treatment |
Q40917460 | Renal amyloidosis as a complication of Familial Mediterranean Fever in children |
Q36851095 | Renal amyloidosis due to familial mediterranean fever misdiagnosed |
Q43779874 | Renal amyloidosis in a female with familial Mediterranean fever: clinical response to treatment with colchicine and infliximab |
Q38541879 | Renal and suprarenal insufficiency secondary to familial Mediterranean fever associated with amyloidosis: a case report |
Q68808319 | Renal protein clearances and selectivity of proteinuria in renal amyloid complicating familial Mediterranean fever |
Q67487878 | Renal transplantation and pregnancy in a patient with familial Mediterranean fever amyloidosis taking tripledrug immunosuppression and colchicine |
Q35218046 | Reproductive system in familial Mediterranean fever: an overview |
Q40319368 | Resistin and visfatin: are they valuable enough to be the differential diagnosis in familial Mediterranean fever with acute appendicitis? |
Q71843687 | Resolving familial Mediterranean fever attacks with interferon alpha |
Q100315331 | Response to: 'Correspondence on 'Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial'' by Satis et al |
Q40255424 | Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children |
Q67747394 | Reversal of the Nephrotic Syndrome by Colchicine in Amyloidosis of Familial Mediterranean Fever |
Q40220401 | Rheumatoid Arthritis and Familial Mediterranean Fever or Sacroiliitis Accompanied by FMF. |
Q59270119 | Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial |
Q40271206 | Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial. |
Q57806590 | Role of fecal calprotectin in the assessment of intestinal inflammation in children with familial Mediterranean fever |
Q40466926 | Rubinstein-Taybi syndrome and familial Mediterranean fever in a single patient: two distinct genetic diseases located on chromosome 16p13.3. |
Q58578291 | S100A12 and vascular endothelial growth factor can differentiate Blau syndrome and familial Mediterranean fever from systemic juvenile idiopathic arthritis |
Q90461489 | SEROLOGICAL SCREENING FOR CELIAC DISEASE IN CHILDREN WITH COLCHICINE-RESISTANT FAMILIAL MEDITERRANEAN FEVER |
Q94958639 | Sacroiliitis associated with familial Mediterranean fever in childhood: a case series and review of literature |
Q88213847 | Sacroiliitis in Children With Familial Mediterranean Fever |
Q40742633 | Sacroiliitis in familial Mediterranean fever |
Q36042372 | Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis |
Q40623159 | Sacroiliitis in familial Mediterranean fever: an unusual presentation in childhood |
Q96579898 | Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever |
Q92963326 | Safety and efficacy of intravenous Colchicine in children with Familial Mediterranean Fever |
Q59416411 | Screening for Familial Mediterranean Fever M694V and V726A Mutations in the Greek Population |
Q93646814 | Screening for familial Mediterranean fever makes sense in Greece |
Q83363260 | Screening for the M694V mutation of the familial Mediterranean fever (FMF) gene in 604 French patients |
Q89099239 | Screening of Free Carnitine and Acylcarnitine Status in Children With Familial Mediterranean Fever |
Q39262471 | Screening of common and novel familial mediterranean fever mutations in south-east part of Turkey. |
Q40401449 | Screening of family members of children with Familial Mediterranean Fever: true-autosomal and pseudo-autosomal inheritance. |
Q40226839 | Secondary amyloidosis in a patient carrying mutations in the familial Mediterranean fever (FMF) and tumour necrosis factor receptor-1 syndrome (TRAPS) genes |
Q36168309 | Secondary bladder amyloidosis with familial Mediterranean fever in a living donor kidney transplant recipient: a case report |
Q90717778 | Secukinumab for psoriasis in a patient with familial Mediterranean fever |
Q45078652 | Selective serotonin reuptake inhibitors in familial Mediterranean fever: are we treating depression or inflammation? |
Q40224961 | Self-medication to treat pain in attacks of familial Mediterranean fever: aiming to find a new approach to pain management |
Q91621373 | Semen analysis in adolescents with familial Mediterranean fever |
Q58259865 | Sequence analysis of amyloid protein AA from a Turkish patient with familial Mediterranean fever: Documentation of its SAA1αderivation |
Q40258587 | Serum 17-OH progesterone and free testosterone levels in women patients with Familial Mediterranean Fever: a pivotal study. |
Q37533429 | Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever |
Q93112319 | Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections |
Q40473672 | Serum amyloid A1 -13 T/C alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. |
Q40558606 | Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis |
Q98957138 | Serum amyloid A1 genotype associates with adult-onset familial Mediterranean fever in patients homozygous for mutation M694V |
Q34244600 | Serum bone markers levels and bone mineral density in familial mediterranean Fever |
Q33624218 | Serum concentration and urinary excretion of beta 2-microglobulin and microalbuminuria in familial Mediterranean fever |
Q35070548 | Serum leptin is not a diagnostic marker for familial Mediterranean fever attacks |
Q40559377 | Serum sIL-2r, IL-6, IL-10 and TNF-? level in familial Mediterranean fever patients |
Q54839485 | Serum uric acid levels in patients with Familial Mediterranean Fever and healthy controls. |
Q88008891 | Serum, salivary, and tissue levels of plasminogen in familial Mediterranean fever, amyloidosis, and chronic periodontitis |
Q33560644 | Severe myalgia in familial Mediterranean fever: clinical and ultrastructural aspects |
Q40522225 | Severe outcome of juvenile idiopathic arthritis (JIA) associated with familial Mediterranean fever (FMF). |
Q92075567 | Short-term follow-up results of children with familial Mediterranean fever after cessation of colchicine: is it possible to quit? |
Q40281220 | Significance of MEFV gene R202Q polymorphism in Turkish familial Mediterranean fever patients |
Q40184265 | Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening |
Q93159131 | Soluble TREM-1 Levels in Familial Mediterranean Fever Related AA-Amyloidosis |
Q40185834 | Sonographic assessment of spleen size in Turkish migrants with Familial Mediterranean fever in Germany |
Q40329099 | Sonographic evaluation of the tendons in familial Mediterranean fever and Behçet's disease |
Q92389939 | Specific changes in faecal microbiota are associated with familial Mediterranean fever |
Q35550749 | Specific glycosylation of alpha(1)-acid glycoprotein characterises patients with familial Mediterranean fever and obligatory carriers of MEFV |
Q38864537 | Spectrum of mutations and carrier frequency of familial Mediterranean fever gene in the Algerian population |
Q40226184 | Spectrum of mutations in the familial Mediterranean fever gene (MEFV) in Turkish patients of the Central Anatolia region: a comparison of two mutation detection system. |
Q88232659 | Spondyloarthritis associated with familial Mediterranean fever: successful treatment with anakinra |
Q40513145 | Spontaneous renal laceration as the presenting feature of polyarteritis nodosa in a patient with familial Mediterranean fever after hepatitis A infection |
Q79207808 | Standardized testing for mutations in familial Mediterranean fever |
Q40884183 | Study of a Spanish family with familial Mediterranean fever |
Q40603446 | Study of the mutation M694V of familial Mediterranean fever in Jews |
Q40855763 | Subacute and chronic joint involvement occurring during the course of familial Mediterranean fever (author's transl) |
Q43073842 | Subcellular localisation of marenostrin/pyrin isoforms carrying the most common mutations involved in familial Mediterranean fever in the presence or absence of its binding partner ASC. |
Q58703969 | Subclinical inflammation in a case of menstruation-induced familial Mediterranean fever: A case report |
Q34267945 | Subtalar arthritis as a presenting symptom of Familial Mediterranean fever: case report and literature review. |
Q40720916 | Successful full-term pregnancy in familial Mediterranean fever complicated with amyloidosis: case report and review of the literature |
Q90454164 | Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus |
Q91624073 | Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review |
Q40664355 | Successful pregnancy in a familial Mediterranean fever patient following assisted reproduction |
Q40573254 | Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient. |
Q40404007 | Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation |
Q40336070 | Successful treatment of renal AA amyloidosis in familial Mediterranean fever with pegylated alpha-2a interferon |
Q53880069 | Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF. |
Q40403953 | Sulphasalazine treatment in protracted familial Mediterranean fever arthritis |
Q85196685 | Summaries for patients. Therapy for patients with familial Mediterranean fever when colchicine is not enough or is not tolerated |
Q72838839 | Suppressor cell deficiency and elevated circulating immune complexes in familial Mediterranean fever |
Q40385028 | Sweet's syndrome in familial Mediterranean fever: possible continuum of the neutrophilic reaction as a new cutaneous feature of FMF. |
Q91563024 | Symptomatic patients with P369S-R408Q mutations: familial Mediterranean fever or mixed auto-inflammatory syndrome? |
Q40814339 | Synovitis in familial Mediterranean fever |
Q40397452 | Systemic AA amyloidosis caused by familial Mediterranean fever and response to colchicine |
Q92069400 | Systemic Amyloidosis in a Patient With Familial Mediterranean Fever and Hodgkin Lymphoma: A Case Report |
Q90266595 | Systemic Lupus Erythematosus with Familial Mediterranean Fever: Case Report and Review of Literature |
Q37215910 | Systemic lupus erythematosus and familial Mediterranean fever: a possible negative association between the two disease entities--report of four cases and review of the literature |
Q93023804 | Takayasu's arteritis with familial Mediterranean fever |
Q30447248 | Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease |
Q72564429 | Temporomandibular joint involvement in familial Mediterranean fever |
Q40875421 | Testicular function in patients with familial Mediterranean fever on long-term colchicine treatment |
Q84612760 | The 3435T polymorphism in the ABCB1 gene and colchicine unresponsiveness in familial Mediterranean fever |
Q34684433 | The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production |
Q90636661 | The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature |
Q40348928 | The Familial Mediterranean Fever Gene as a Modifier of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome |
Q89099309 | The Frequency of Ankylosing Spondylitis Among Patients With Familial Mediterranean Fever and the Relationship With M694V Mutation |
Q55073641 | The IL-1 inhibitor Canakinumab for Familial Mediterranean Fever: the Greek experience in 12 patients. |
Q90996197 | The Influence of Concomitant Disorders on Disease Severity of Familial Mediterranean Fever in Children |
Q36605185 | The M694V mutation in Armenian-Americans: a 10-year retrospective study of MEFV mutation testing for familial Mediterranean fever at UCLA. |
Q34580099 | The M694V variant of the familial Mediterranean fever gene is associated with sporadic early-onset Alzheimer's disease in an Italian population sample |
Q94488569 | The MEFV gene and its association with familial Mediterranean fever, severe atopy, and recurrent respiratory tract infections |
Q37689981 | The MEFV gene pathogenic variants and phenotype-genotype correlation in children with familial Mediterranean fever in the Çanakkale population |
Q40233402 | The MEFV mutations and their clinical correlations in children with familial Mediterranean fever in southeast Turkey |
Q96430835 | The Possible Relationship Between Familial Mediterranean Fever and Chronic Nonbacterial Osteomyelitis: Coincidence or Coexistence? |
Q92382306 | The Role of Familial Mediterranean Fever Gene Mutation in Treatment of Infantile Colitis With Resistant Perianal Fistula |
Q40146198 | The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing |
Q97518819 | The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review |
Q90121914 | The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods |
Q40495413 | The anemia of familial Mediterranean fever disease. |
Q91275530 | The application of precision medicine in diagnosing familial Mediterranean fever |
Q81431921 | The arthritis of familial Mediterranean fever |
Q40961989 | The arthritis of familial Mediterranean fever (FMF). |
Q92429708 | The assessment of tocilizumab therapy on recurrent attacks of patients with familial Mediterranean fever: A retrospective study of 15 patients |
Q45744985 | The association of Familial Mediterranean Fever and cryptogenic cirrhosis |
Q36616088 | The association of endoplasmic reticulum aminopeptidase-1 (ERAP-1) with Familial Mediterranean Fever (FMF) |
Q28195144 | The association of polyarteritis nodosa and familial Mediterranean fever |
Q40401212 | The clinical and genetical features of 124 children with Familial Mediterranean fever: experience of a single tertiary center |
Q72149853 | The clinical features of Familial Mediterranean Fever of elderly onset |
Q43604756 | The coexistance of familial Mediterranean fever and Addison disease |
Q40663182 | The coexistence of familial Mediterranean fever and polyarteritis nodosa; report of a case |
Q45094161 | The coexistence of familial Mediterranean fever with multiple sclerosis |
Q34316398 | The coincidence of familial mediterranean Fever and hypereosinophilia in a patient with hereditary elliptocytosis |
Q40856805 | The complement system in familial Mediterranean fever: studies in 41 families (author's transl) |
Q34598115 | The contribution of SAA1 polymorphisms to Familial Mediterranean fever susceptibility in the Japanese population |
Q96021704 | The contribution of diet preference to the disease course in children with familial Mediterranean fever: a cross-sectional study |
Q28190162 | The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever |
Q87874284 | The country of residence affects the phenotype of familial Mediterranean fever: is it real or a selection bias? |
Q27657294 | The crystal structure of human pyrin b30.2 domain: implications for mutations associated with familial Mediterranean fever |
Q40761716 | The cutaneous manifestations in children with familial Mediterranean fever (recurrent hereditary polyserositis). A six-year study. |
Q40049239 | The detection of a novel insertion mutation in exon 2 of the MEFV gene associated with familial mediterranean fever in a moroccan family |
Q40489030 | The effect of colchicine on the periodicity of the spontaneous and induced respiratory burst of granulocytes and monocytes during familial Mediterranean fever |
Q40494375 | The effect of colcichine and iodine-lithium-alpha-dextrin on the phagocytosis of granulocytes and monocytes in patients with familial Mediterranean fever |
Q92429780 | The effect of genotype on musculoskeletal complaints in patients with familial Mediterranean fever |
Q40522258 | The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: A double-blind, placebo-controlled trial |
Q40404001 | The effect of plasminogen activator inhibitor-1 -675 4G/5G polymorphism on familial Mediterranean fever (FMF) disease. |
Q24656095 | The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever |
Q97522421 | The efficacy of anti- IL-1 treatment in three patients with coexisting familial Mediterranean fever and multiple sclerosis |
Q83464874 | The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis |
Q40522252 | The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients. |
Q40645507 | The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: a pilot study |
Q40526980 | The efficacy of interferon-alpha in a patient with resistant familial Mediterranean fever complicated by polyarteritis nodosa |
Q45745012 | The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF). |
Q92946631 | The evaluation of anxiety, depression and quality of life scores of children and adolescents with familial Mediterranean fever |
Q40096461 | The evaluation of renal hemodynamics changes in Familial Mediterranean fever with color Doppler sonography |
Q88675678 | The evaluation of salivary oxidative stress in patients with familial Mediterranean fever and chronic periodontitis |
Q36521208 | The expanded clinical profile and the efficacy of colchicine therapy in Egyptian children suffering from familial Mediterranean fever: a descriptive study |
Q46256254 | The familial Mediterranean fever (FMF) 50 score: does it work in a controlled clinical trial? Re-analysis of the trial of rilonacept for patients with colchicine resistant or intolerant FMF. |
Q40157162 | The familial Mediterranean fever (FMF) 50 score: does it work in a controlled clinical trial? Re-analysis of the trial of rilonacept for patients with colchicine-resistant or intolerant FMF. |
Q40449242 | The familial Mediterranean fever (MEFV) gene may be a modifier factor of inflammatory bowel disease in infancy. |
Q40516407 | The familial Mediterranean fever (MEVF) gene as a modifier of Crohn's disease |
Q40644920 | The familial Mediterranean fever gene--cloned at last |
Q24291475 | The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments |
Q24642151 | The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment |
Q40850560 | The familial mediterranean fever (author's transl) |
Q28142947 | The familial mediterranean fever protein interacts and colocalizes with a putative Golgi transporter |
Q40296783 | The first case of familial Mediterranean fever associated with renal amyloidosis in Korea |
Q40222703 | The frequency of Familial Mediterranean fever gene mutations and genotypes at Kirikkale and comparison with the mean of regional MEFV mutation frequency of Turkey |
Q40307524 | The frequency of familial Mediterranean fever in an emergency unit. |
Q34666251 | The frequency of familial mediterranean Fever related amyloidosis in renal waiting list for transplantation |
Q93000185 | The frequency of juvenile spondyloarthropathies in childhood familial Mediterranean fever |
Q40409577 | The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis |
Q40694233 | The gene causing familial Mediterranean fever maps to the short arm of chromosome 16 in Druze and Moslem Arab families |
Q74584995 | The gene for familial Mediterranean fever has been identified |
Q35196240 | The gene for familial Mediterranean fever in both Armenians and non-Ashkenazi Jews is linked to the alpha-globin complex on 16p: evidence for locus homogeneity |
Q40692661 | The gene for familial Mediterranean fever is mapped to 16p 13.3- p13.1 with evidence for homogeneity. |
Q40621671 | The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. |
Q40785349 | The immune regulation in familial Mediterranean fever (FMF). |
Q38219867 | The impact of familial Mediterranean fever on reproductive system |
Q38020010 | The impact of familial Mediterranean fever on women's health |
Q97893572 | The importance of Mediterranean fever gene in familial Mediterranean fever |
Q90649329 | The influence of genotype on disease severity and concomitant diseases in familial Mediterranean fever patients |
Q39362276 | The liver in familial Mediterranean fever: is it involved? |
Q83774112 | The medical odyssey of a boy with arthritis of familial Mediterranean fever |
Q34177814 | The metaraminol provocation test in the diagnosis of familial Mediterranean fever |
Q92895038 | The missing link between familial Mediterranean fever and recurrent aseptic meningitis |
Q36566398 | The multi-face expression of familial Mediterranean fever in the child |
Q40601396 | The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the disease |
Q101461304 | The musculoskeletal system manifestations in children with familial Mediterranean fever |
Q38400573 | The myths we believed in familial Mediterranean fever: what have we learned in the past years? |
Q40522710 | The outcome of pregnancy in the wives of men with familial mediterranean fever treated with colchicine |
Q40412399 | The population genetics of familial mediterranean fever: a meta-analysis study |
Q46361632 | The portrait of Familial Mediterranean Fever in N. Greek pediatric patients: a 30-year experience. |
Q104489877 | The possession of exon 2 or exon 3 variants in the MEFV gene promotes inflammasome activation in Japanese patients with familial Mediterranean fever with a heterozygous exon 10 mutation |
Q40340543 | The prevalence of Behçet's syndrome, familial Mediterranean fever, HLA-B51 and MEFV gene mutations among ethnic Armenians living in Istanbul, Turkey |
Q40212939 | The prevalence of Familial Mediterranean Fever common gene mutations in patients with simple febrile seizures |
Q40230871 | The prevalence of atopy in patients with familial Mediterranean fever and Behçet's disease. |
Q40522278 | The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design. |
Q70095952 | The prevention of amyloidosis in familial Mediterranean fever with colchicine |
Q40627083 | The relation between familial Mediterranean fever and amyloidosis |
Q60921718 | The relation of novel cardiovascular risk parameters in patients with familial Mediterranean fever |
Q40497943 | The relations between attacks and menstrual periods and pregnancies of familial Mediterranean fever patients. |
Q40211230 | The relationship between familial Mediterranean fever gene (MEFV) mutations and clinical and radiologic parameters in multiple sclerosis patients |
Q40140759 | The relationship between red cell distribution width and homozygous M694V mutation in familial Mediterranean fever patients |
Q40308353 | The relative contribution of environmental and genetic factors to phenotypic variation in familial Mediterranean fever (FMF). |
Q40145665 | The report of sequence analysis on familial Mediterranean fever gene (MEFV) in South-eastern Mediterranean region (Kahramanmaraş) of Turkey. |
Q36981046 | The risk of familial Mediterranean fever in MEFV heterozygotes: a statistical approach |
Q100564332 | The role of azurocidin in patients with familial Mediterranean fever and AA amyloidosis and its association with cardiovascular risk factors |
Q37592604 | The role of inflammatory cytokines and NF-kappaB/MAPK signaling pathways in the evolution of familial Mediterranean fever: current clinical perspectives and potential therapeutic approaches |
Q40321296 | The role of interleukin-1 and interleukin-1-receptor antagonist in development of familial mediterranean fever and other autoinflammatory diseases |
Q36638119 | The role of neutrophil lymphocyte ratio to leverage the differential diagnosis of familial Mediterranean fever attack and acute appendicitis |
Q40299613 | The role of regulatory T cells in familial Mediterranean fever (FMF). |
Q39646251 | The role of the pro-apoptotic protein Siva in the pathogenesis of Familial Mediterranean fever: A structural and functional analysis |
Q78600172 | The significance of paired MEFV mutations in individuals without symptoms of familial Mediterranean fever |
Q40118364 | The significance of urinary beta-2 microglobulin level for differential diagnosis of familial Mediterranean fever and acute appendicitis |
Q34314032 | The spectrum of Familial Mediterranean Fever (FMF) mutations |
Q41929078 | The spectrum of Familial Mediterranean Fever gene (MEFV) mutations and genotypes in Iran, and report of a novel missense variant (R204H). |
Q37616913 | The spectrum of MEFV clinical presentations--is it familial Mediterranean fever only? |
Q40434939 | The spectrum of familial Mediterranean fever |
Q40506669 | The spectrum of familial Mediterranean fever gene mutations in Arabs: report of a large series. |
Q81760826 | The utility of genetic testing in the diagnosis of familial Mediterranean fever |
Q40464848 | The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study. |
Q34039000 | Therapeutic approach to familial Mediterranean fever: a review update. |
Q40562096 | Third International Conference on Familial Mediterranean Fever and Other Hereditary Inflammatory Disorders. |
Q34714963 | Thoracic and lung involvement in familial Mediterranean fever (FMF). |
Q40375174 | Thoracic impairment from familial Mediterranean fever: review of the literature and a case study |
Q78350794 | Thoughts on the proposed links between Behçet's disease and familial Mediterranean fever |
Q40222592 | Three Japanese patients (mother and two children) with familial Mediterranean fever associated with compound heterozygosity for L110P/E148Q/M694I and an autosomal true dominant inheritance pattern |
Q40057959 | Three cases with familial Mediterranean fever misdiagnosed as juvenile idiopathic arthritis |
Q38025863 | Three family members with familial Mediterranean fever carrying the M694V mutation showed different clinical presentations |
Q40193793 | Three patients with familial Mediterranean fever: a possible underdiagnosed entity in Japan |
Q40226177 | Thyroid autoimmunity in patients with Familial Mediterranean Fever: preliminary results |
Q33742607 | Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever |
Q86513694 | Tocilizumab is effective in a familial Mediterranean fever patient complicated with histologically proven recurrent fasciitis and myositis |
Q90390875 | Tofacitinib for familial Mediterranean fever: a new alternative therapy? |
Q91778153 | Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review |
Q92779752 | Toll-like receptor 2 is overexpressed in Familial Mediterranean fever patients and is inhibited by colchicine treatment |
Q60947832 | Toll-like receptor 4 promoter polymorphisms in a familial mediterranean fever patient with asymptomatic bacteriuria |
Q28318315 | Toxic myopathy with kidney failure as a colchicine side effect ifn familial Mediterranean fever |
Q92442379 | Transient Pancytopenia and Granulocyte Abnormalities After Suicide Attempt With Colchicine in a Patient With Familial Mediterranean Fever |
Q56779443 | Transmission of familial Mediterranean fever mutation after bone marrow transplantation and successful treatment with anakinra |
Q80697338 | Transmission of familial Mediterranean fever mutations following bone marrow transplantation |
Q77292705 | Treating familial Mediterranean fever with prazosin hydrochloride |
Q39237366 | Treatment of Crohn's disease and familial Mediterranean fever by leukopheresis: single shot for two targets |
Q40154874 | Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents |
Q72428382 | Treatment of familial Mediterranean fever |
Q40072718 | Treatment of familial Mediterranean fever with anakinra in patients unresponsive to colchicine |
Q55044035 | Treatment of familial Mediterranean fever with anakinra. |
Q40849209 | Treatment of familial Mediterranean fever with colchicine |
Q26852166 | Treatment of familial Mediterranean fever: colchicine and beyond |
Q64092000 | Treatment of familial mediterranean fever with canakinumab in patients who are unresponsive to colchicine |
Q82232520 | Treatment of severe acne in Familial Mediterranean Fever |
Q40466232 | Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents. |
Q102131030 | Triggering factors for febrile attacks in Japanese patients with familial Mediterranean fever |
Q40299621 | Triggers for attacks in familial Mediterranean fever: application of the case-crossover design |
Q87194847 | Triple Disease Combination: Familial Mediterranean Fever, Crohn's Disease, and Chronic Idiopathic Urticaria with Angioedema |
Q40569313 | Tuberculous ileitis in a renal transplant recipient with familial Mediterranean fever: Gray-scale and power Doppler sonographic findings |
Q40404327 | Tumor markers in familial Mediterranean fever and their correlation with the frequency of attacks |
Q68116704 | Tumor necrosis factor in familial Mediterranean fever |
Q67586372 | Tumor necrosis factor in pathogenesis of familial Mediterranean fever |
Q40556301 | Turkish children with recurrent abdominal pain and fever: familial Mediterranean fever |
Q91144605 | Twenty-Year Experience of a Single Referral Center on Pediatric Familial Mediterranean Fever: What Has Changed Over the Last Decade? |
Q90005063 | Two birds with one stone: Anakinra for both gout and Familial Mediterranean fever attacks in a patient with renal transplant |
Q44119922 | Two cases of familial Mediterranean fever associated with sarcoidosis (Lofgren's syndrome) and rheumatoid arthritis |
Q40213139 | Two elderly cases of familial mediterranean fever with rheumatoid arthritis |
Q40484457 | Two sisters with familial Mediterranean fever: lack of correlation between genotype and phenotype? |
Q40388419 | Type 1 diabetes mellitus associated with autoimmune thyroid disease, celiac disease and familial Mediterranean fever: case report. |
Q89483371 | Typical Familial Mediterranean Fever associated with the heterozygous missense sequence p.T577N variant of the MEFV gene: Report on two Northern European Caucasians relatives in France |
Q90759312 | Ulcerative Colitis and Familial Mediterranean Fever: Can Anakinra Treat Both? |
Q92371811 | Ulceronecrotic Lesions in a Man with Familial Mediterranean Fever: A Quiz |
Q59429087 | Underlying causes of persistently elevated acute phase reactants in patiens with Familial Mediterranean Fever |
Q40147920 | Unified Modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes |
Q46156694 | Unified modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes |
Q40371658 | Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation |
Q40538098 | Unusual cutaneous lesions of familial Mediterranean fever |
Q51613151 | Unusual presentation of familial Mediterranean fever: atypical hyperaemic recurrent skin lesions. |
Q35548920 | Unusual presentation of familial Mediterranean fever: role of genetic diagnosis |
Q26745728 | Update on Auto-Inflammatory Diseases and Familial Mediterranean Fever |
Q26749573 | Update on Pyrin Functions and Mechanisms of Familial Mediterranean Fever |
Q40682646 | Update on familial Mediterranean fever |
Q90346728 | Update on the epidemiology and disease outcome of Familial Mediterranean fever |
Q90727834 | Update on the management of colchicine resistant Familial Mediterranean Fever (FMF) |
Q40747709 | Urinary albumin excretion in patients with familial Mediterranean fever: a pilot study. |
Q72156174 | Urinary neopterin level in familial Mediterranean fever |
Q40504687 | Urine leukotriene B4 in familial Mediterranean fever and other forms of right lower abdominal pain |
Q40153680 | Usefulness of Small Intestinal Endoscopy in a Case of Adult-onset Familial Mediterranean Fever Associated with Jejunoileitis |
Q37376286 | Usefulness of video-capillaroscopy in clinical practice: systematic review of indications and results in rheumatology and in non-rheumatic disorders |
Q90961682 | Utility of new red cell parameters for distinguishing functional iron deficiency from absolute iron deficiency in children with familial Mediterranean fever |
Q33650709 | Validation of the new paediatric criteria for the diagnosis of familial Mediterranean fever: data from a mixed population of 100 children from the French reference centre for auto-inflammatory disorders |
Q39366917 | Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups |
Q53924650 | Vasculitis associated with familial Mediterranean fever: a study on 16 french adult cases. |
Q36487754 | Vasculitis in siblings with familial Mediterranean fever: a report of three cases and review of the literature |
Q64275111 | Vertebral artery dissection associated with familial Mediterranean fever and Behçet's disease |
Q40230885 | Vitamin B12 levels in familial Mediterranean fever patients treated with colchicine. |
Q99559794 | Vitamin D binding protein genotype frequency in familial Mediterranean fever patients |
Q36846702 | Vitamin D levels in children with familial Mediterranean fever |
Q95372038 | Vitamin D levels in children with familial Mediterranean fever |
Q38681895 | What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review |
Q40743694 | What is your diagnosis? Destructive arthropathy in familial mediterranean fever |
Q92124436 | Wheat Consumption Leads to Immune Activation and Symptom Worsening in Patients with Familial Mediterranean Fever: A Pilot Randomized Trial |
Q35332027 | Whipple's disease, familial Mediterranean fever, adult-onset Still's disease, and enteropathic arthritis |
Q40746406 | Whipple's disease, familial Mediterranean fever, and adult-onset Still's disease |
Q36597667 | Whippleʼs disease, familial Mediterranean fever, and adult-onset Stillʼs disease |
Q92275749 | Wolff-Parkinson-White Syndrome in an Adolescent With Familial Mediterranean Fever: A Coincidence? |
Q31804988 | Y688X, the first nonsense mutation in familial Mediterranean fever (FMF). |
Q53847427 | Zytokin profiles in familial Mediterranean fever patients: IL-18 as a major cytokine and potential biomarker or target. |
Q91280730 | [A Case of FMF (Familial Mediterranean Fever) with HLA-B*39 and HLA-B*40 as Disease-promoting Factors] |
Q70513912 | [A Dutch family with familial Mediterranean fever] |
Q70024449 | [Acute intestinal occlusion in periodic disease (or familial Mediterranean fever)] |
Q83390945 | [Anakinra in familial Mediterranean fever] |
Q77662076 | [Anesthetic complications of familial Mediterranean fever] |
Q86960705 | [Arthritis as presentation of familial Mediterranean fever] |
Q101573468 | [Atypical clinical presentation of familial Mediterranean fever resembling colonic diverticulitis in an elderly patient:a case report] |
Q71450438 | [Biliary acids in familial mediterranean fever (author's transl)] |
Q93647756 | [C5a inhibitor as a regulator of inflammation in serosal and synovial tissues--the significance of its deficiency in familial Mediterranean fever] |
Q91229845 | [Evidence-based treatment recommendations for familial Mediterranean fever : A joint statement by the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology] |
Q90106552 | [FAMILIAL MEDITERRANEAN FEVER IN CHILDREN: ENDOSCOPIC CONDITION ОF THE GASTROINTESTINAL TRACT IN DIFFERENT PERIODS OF THE DISEASE] |
Q91269492 | [Familial Mediterranean Fever - FMF By Prof. Alon Pras, Prof. Avi Livne and Prof. Yehuda Shoenfeld] |
Q71501853 | [Familial Mediterranean fever (FMF) (author's transl)] |
Q81161115 | [Familial Mediterranean fever and other hereditary recurrent inflammatory diseases] |
Q64969804 | [Familial Mediterranean fever – an important disease in a globalised world]. |
Q40451091 | [Familial Mediterranean fever: MEFV gene mutations and treatment]. |
Q77421303 | [Familial mediterranean fever is a hereditary disorder of the neutrophil] |
Q74589977 | [Genetic diagnosis of periodic diseases (familial mediterranean fever or FMF)] |
Q40880155 | [HLA markers and periodic disease [familial Mediterranean fever (F.M.F.)] (author's transl)] |
Q84333919 | [Imaging features of joint involvement in Familial Mediterranean Fever: A case report and value of diffusion weighted MR imaging] |
Q68042836 | [Metaraminol provocation test for familial Mediterranean fever] |
Q40481656 | [Modulation of endotoxin-induced respiratory splash of granulocytes and monocytes in patients with Familial Mediterranean Fever by iodine-lithium-alpha-dextrin and sodium thiosulfate] |
Q40376766 | [Molecular diagnostics of hereditary fever syndromes. Familial Mediterranean fever (FMF), hyperimmunoglobulin D syndrome (HIDS), tumor necrosis factor receptor-associated periodic syndrome (TRAPS), cryopyrin-associated periodic syndrome (CAPS: FCAS, |
Q71354600 | [Muscle pains in familial Mediterranean fever] |
Q40457635 | [Myalgia in familial Mediterranean fever] |
Q68743236 | [Provocation test using metaraminol in a case of familial Mediterranean fever] |
Q53791546 | [Provocation test using metaraminol in familial Mediterranean fever] |
Q67264290 | [Report of a case of familial Mediterranean fever] |
Q73547839 | [Report of the Third International Conference on familial Mediterranean fever and hereditary inflammatory diseases. La Grand Motte, September 2002] |
Q100390856 | [Results of the systematic literature search as basis for the "Evidence-based treatment recommendations for familial Mediterranean fever patients with insufficient response or intolerability to colchicine" of the Society for Pediatric and Adolescent |
Q74318242 | [Second international conference on familial Mediterranean fever, Antalya (Turkey), 3-7 May 2000] |
Q73819404 | [Turkish children with abdominal pain and fever: familial Mediterranean fever] |
Q326224 | (S)-(−)-colchicine | medical condition treated | P2175 |
Q14881867 | MEFV | genetic association | P2293 |
Search more.